
        <html>
        <head>
            <style>
                body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; }
                h3 { color: #333; }
                .question { margin-bottom: 15px; }
                .options { margin-left: 20px; margin-bottom: 10px; }
                .solution { background: #f8f9fa; padding: 10px; border-left: 4px solid #007bff; }
                .credits { text-align: center; margin-top: 20px; font-size: 18px; }
                .rainbow-text { 
                    background: linear-gradient(90deg, red, orange, yellow, green, blue, indigo, violet); 
                    -webkit-background-clip: text; 
                    color: transparent; 
                    font-weight: bold; 
                }
            </style>
        </head>
        <body>
        
            <div class="question">
                <h3>Question No: 1</h3>
                <p><b>Which of the following parameters is used to indicate the ability of a drug to produce the desired therapeutic effect relative to a toxic effect?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Bioavailability</li><li>2. Therapeutic Index</li><li>3. Potency</li><li>4. Efficacy</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoListParagraphCxSpFirst" style="margin-left: 18.0pt; mso-add-space: auto; text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span style="font-size: 12pt;"><span lang="EN-US" style="line-height: 115%; font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font-style: normal; font-variant: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman';"> &nbsp;&nbsp;&nbsp;</span></span></span><strong style="mso-bidi-font-weight: normal;"><span lang="EN-US" style="line-height: 115%; font-family: 'Times New Roman', serif;">Therapeutic Index: </span></strong><span lang="EN-US" style="line-height: 115%; font-family: 'Times New Roman', serif;">It is calculated by dividing LD<sub>50</sub> to ED<sub>50</sub>. LD<sub>50</sub> is the minimum dose required to kill 50% of animals and hence is a measure of drug toxicity. ED<sub>50</sub> is the minimum dose required to produce clinical effect in 50% of population and hence is a measure of drug potency (Lower dose required to produce effect, higher potency and vice versa).</span></span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left: 18.0pt; mso-add-space: auto; text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><span style="font-size: 12pt;"><!-- [if !supportLists]--><span lang="EN-US" style="line-height: 115%; font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font-style: normal; font-variant: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman';"> &nbsp;&nbsp;&nbsp;</span></span></span><span lang="EN-US" style="line-height: 115%; font-family: 'Times New Roman', serif;">Lithium is an example of a drug with a very low therapeutic index (TI), which requires frequent monitoring of the plasma level to achieve the balance between the desired effect and untoward toxicity. </span></span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left: 18.0pt; mso-add-space: auto; text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><span style="font-size: 12pt;"><!-- [if !supportLists]--><span lang="EN-US" style="line-height: 115%; font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font-style: normal; font-variant: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman';"> &nbsp;&nbsp;&nbsp;</span></span></span><strong style="mso-bidi-font-weight: normal;"><span lang="EN-US" style="line-height: 115%; font-family: 'Times New Roman', serif;">Bioavailability </span></strong><span lang="EN-US" style="line-height: 115%; font-family: 'Times New Roman', serif;">of the drug is the fraction of the drug that reaches the blood stream unaltered.</span></span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left: 18.0pt; mso-add-space: auto; text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><span style="font-size: 12pt;"><!-- [if !supportLists]--><span lang="EN-US" style="line-height: 115%; font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font-style: normal; font-variant: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman';"> &nbsp;&nbsp;&nbsp;</span></span></span><strong style="mso-bidi-font-weight: normal;"><span lang="EN-US" style="line-height: 115%; font-family: 'Times New Roman', serif;">Efficacy </span></strong><span lang="EN-US" style="line-height: 115%; font-family: 'Times New Roman', serif;">is the ability of the drug to generate maximal drug effect by acting on target. It is the most important parameter of drug clinically. </span></span></p><p class="MsoListParagraphCxSpLast" style="margin-left: 18.0pt; mso-add-space: auto; text-indent: -18.0pt; mso-list: l0 level1 lfo1;"><span style="font-size: 12pt;"><!-- [if !supportLists]--><span lang="EN-US" style="line-height: 115%; font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font-style: normal; font-variant: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-weight: normal; font-stretch: normal; line-height: normal; font-family: 'Times New Roman';"> &nbsp;&nbsp;&nbsp;</span></span></span><strong style="mso-bidi-font-weight: normal;"><span lang="EN-US" style="line-height: 115%; font-family: 'Times New Roman', serif;">Potency</span></strong><span lang="EN-US" style="line-height: 115%; font-family: 'Times New Roman', serif;"> of the drug is the amount of drug needed to produce a given response. The dose of drug required for an effect depends both on affinity and efficacy. Potency of two drugs actin on different targets can also be compared. If lesser dose is required for a particular effect, higher is the potency and vice versa. </span></span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 2</h3>
                <p><b>Anticholinergic side effect is:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Dryness</li><li>2. Sweating</li><li>3. Salivation</li><li>4. Increased GIT motility</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Anti-cholinergic agents / Muscarinic antagonists are the class of drugs which competitively inhibit the effect of acetylcholine at muscarinic receptors. Therefore, decreasing secretion from glands leads to dryness. </li><li><b>Side effects of anti-cholinergic agents can be remembered by the following mnemonic:</b></li><ul type ="circle"> <li>Hot as hare:</b> Increased temperature</li><li>Blind as bat:</b> Mydriasis</li><li>Dry as bone:</b> Dry mouth, dry eye and dry skin</li><li>Red as beet-flushed face</li><li>Mad as hatter:</b> Delirium </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 3</h3>
                <p><b>Which drug is used to prevent aspiration and decrease the secretions?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Atropine</li><li>2. Adrenaline</li><li>3. Noradrenaline</li><li>4. Dopamine</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoListParagraphCxSpFirst" style="margin-left: 18.0pt; mso-add-space: auto; text-indent: -18.0pt; mso-list: l1 level1 lfo1; background: white; mso-background-themecolor: background1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Atropine is a clinically relevant anticholinergic drug, which blocks inhibitory effects of the parasympathetic neurotransmitter acetylcholine on heart rate leading to tachycardia.</span></p><p class="MsoListParagraphCxSpMiddle" style="margin-left: 18.0pt; mso-add-space: auto; text-indent: -18.0pt; mso-list: l1 level1 lfo1; background: white; mso-background-themecolor: background1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Atropine is a prescription medicine used to treat the symptoms of low heart rate (bradycardia), reduce salivation and bronchial secretions before surgery or as an antidote for overdose of cholinergic drugs or mushroom poisoning.</span></p><p class="MsoListParagraphCxSpLast" style="margin-left: 18.0pt; mso-add-space: auto; text-indent: -18.0pt; mso-list: l1 level1 lfo1; background: white; mso-background-themecolor: background1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">For adults, to reduce salivation and bronchial secretions, an oral dose of 0.4 mg is suggested, which may be repeated every 4 to 6 hours as needed.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 18.0pt; text-indent: -18.0pt; line-height: normal; mso-list: l0 level1 lfo2; tab-stops: list 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 12.0pt;">Mechanism of action:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"> Atropine is an <strong>anticholinergic drug</strong> (a muscarinic receptor antagonist), meaning it blocks the effects of <strong>acetylcholine</strong> on the <strong>parasympathetic nervous system</strong>. By doing so, it reduces <strong>secretions</strong> in the mouth, respiratory tract, and other areas.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 18.0pt; text-indent: -18.0pt; line-height: normal; mso-list: l0 level1 lfo2; tab-stops: list 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 12.0pt;">Use in anesthesia:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"> Atropine is commonly used preoperatively to <strong>decrease salivary and respiratory secretions</strong>. This helps to prevent aspiration of secretions into the lungs during surgery.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 18.0pt; text-indent: -18.0pt; line-height: normal; mso-list: l0 level1 lfo2; tab-stops: list 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 12.0pt;">Other effects:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"> Atropine can also increase heart rate by inhibiting the parasympathetic effects on the heart (useful in bradycardia management).</span></p><h3><span style="font-size: 12.0pt;">Explanation of the Distractors:</span></h3><p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l2 level1 lfo3; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong>b) Adrenaline (Epinephrine):</strong></p><ul type="disc"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l2 level2 lfo3; tab-stops: list 72.0pt;"><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;">Adrenaline is a <strong>sympathomimetic</strong> drug that increases heart rate, bronchodilation, and blood pressure. It is used in emergencies like <strong>anaphylaxis</strong> and <strong>cardiac arrest</strong>, but it does not reduce secretions or prevent aspiration.</span></li></ul></ul><p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l2 level1 lfo3; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong>c) Noradrenaline (Norepinephrine):</strong></p><ul type="disc"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l2 level2 lfo3; tab-stops: list 72.0pt;"><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;">Noradrenaline is a potent <strong>vasoconstrictor</strong> and is mainly used to increase blood pressure in conditions like <strong>shock</strong>. It does not have anticholinergic properties and does not reduce secretions.</span></li></ul></ul><p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l2 level1 lfo3; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong>d) Dopamine:</strong></p><ul type="disc"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l2 level2 lfo3; tab-stops: list 72.0pt;"><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;">Dopamine is a <strong>catecholamine</strong> that has dose-dependent effects on heart rate, blood pressure, and renal blood flow. It is not used to prevent aspiration or to reduce secretions</span></li></ul></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 4</h3>
                <p><b>What is the drug of choice (DOC) for managing pulmonary edema in acute heart failure?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Spironolactone</li><li>2. Nesiritide</li><li>3. Furosemide</li><li>4. Nitroglycerine</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p>Furosemide, a loop diuretic, is the first-line treatment for pulmonary oedema in acute heart failure as it helps reduce fluid overload by promoting diuresis, thereby decreasing the volume in the lungs. <strong>for the distractors:</strong></p><ul><li><strong>Spironolactone: </strong>Spironolactone is a potassium-sparing diuretic used in chronic heart failure, not for acute pulmonary oedema.</li><li><strong>Nesiritide:</strong> Nesiritide, a BNP analogue, is used if there is no response to initial treatments like furosemide or nitroglycerine, but it is not the first-line treatment.</li><li><strong>Nitroglycerine:</strong> IV Nitroglycerine reduces preload and is used, if there is no response to diuretics like furosemide, but it is not the first-line treatment for pulmonary oedema.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 5</h3>
                <p><p><strong>What is the primary use of Protamine sulphate?</strong></p></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Reversal of Warfarin effects</li><li>2. Antidote for Heparin overdose</li><li>3. Reversal of Direct Oral Anticoagulants (DOACs)</li><li>4. Treatment of thrombotic disorders</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul type="disc"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l1 level1 lfo1; tab-stops: list 36.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%;">B) Antidote for Heparin overdose:</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif;"> Protamine sulfate is specifically indicated for reversing the anticoagulant effects of Heparin. It binds to Heparin to neutralize its effects, making it an effective antidote during bleeding episodes or surgical procedures.</span></li></ul><h3 style="line-height: 115%;"><span style="font-size: 12.0pt; line-height: 115%;">Distractor Rationale:</span></h3><p style="margin-left: 36.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong>A) Reversal of Warfarin effects:</strong> This is incorrect. The reversal of Warfarin is achieved using Vitamin K and prothrombin complex concentrates, not Protamine sulphate.</p><p style="margin-left: 36.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong>C) Reversal of Direct Oral Anticoagulants (DOACs):</strong> This is incorrect. Protamine sulphate does not effectively reverse the anticoagulant effects of DOACs. Specific agents like Andexanet alfa for Factor Xa inhibitors and Idarucizumab for Dabigatran are used instead.</p><p style="margin-left: 36.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l0 level1 lfo2; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong>D) Treatment of thrombotic disorders:</strong> This is incorrect. Protamine sulphate is not used to treat thrombotic disorders; it is used specifically to reverse the effects of Heparin.</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 6</h3>
                <p><b>Which of the following is the longest acting form of insulin?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Glargine</li><li>2. NPH</li><li>3. Degludec</li><li>4. Regular insulin</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 36.0pt; line-height: normal;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Degludec</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"> is the <strong>longest acting</strong> form of insulin available, with a duration of action up to <strong>42 hours</strong>. This ultra-long-acting insulin provides stable basal insulin coverage with a very flat peak, which helps in maintaining consistent blood glucose levels over an extended period. It is administered subcutaneously and is typically dosed once daily.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 36.0pt; line-height: normal;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Distractors:</span></strong></p><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">A: Glargine:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Glargine</strong> insulin is also a long-acting insulin, with a duration of about <strong>24 hours</strong>. However, it forms <strong>white crystals</strong> when mixed with other insulins, which may interfere with its stability and action. Its duration is shorter compared to <strong>Degludec</strong>.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">B: NPH:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>NPH (Neutral Protamine Hagedorn)</strong> insulin is an intermediate-acting insulin with a duration of around <strong>12&ndash;16 hours</strong>, significantly shorter than both <strong>Glargine</strong> and <strong>Degludec</strong>.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">D: Regular insulin:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Regular insulin</strong> is a short-acting insulin with a <strong>duration of 5&ndash;8 hours</strong>, and it is typically used for <strong>mealtime control</strong> rather than long-term basal insulin therapy.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Clinical Application:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"> <strong>Degludec</strong> is particularly useful in patients requiring <strong>stable, extended basal insulin</strong> control, offering an advantage over other insulins with shorter durations.</span></li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 7</h3>
                <p><b>An unexpected effect of the drug, is known as:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Side effect</li><li>2. Adverse effect</li><li>3. Toxic reaction</li><li>4. Allergic reaction</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ol start="1" type="1"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt;">Adverse effects</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"> are <strong>harmful and unintended reactions</strong> that occur during normal drug administration. They are <strong>unexpected</strong> and can range from mild to severe. <strong>Adverse effects</strong> can occur regardless of whether the drug is taken correctly or not, and they often require intervention, such as discontinuing the drug or adjusting the dosage.</span></li></ul></ol><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 36.0pt; line-height: normal;"><strong><span lang="EN-US" style="font-size: 12.0pt;">Distractors:</span></strong></p><ol start="1" type="1"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt;">a. Side effect:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"><br>A <strong>side effect</strong> is an <strong>expected</strong> and <strong>predictable</strong> secondary effect that can occur alongside the desired therapeutic effect. These are often less harmful and usually not severe. Side effects are common, but they are not unexpected like <strong>adverse effects</strong>.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt;">c. Toxic reaction:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"><br>A <strong>toxic reaction</strong> refers to a <strong>drug's harmful effect</strong> caused by an excessive dose or prolonged use, leading to <strong>damage to organs or tissues</strong>. It is a <strong>specific type of adverse effect</strong> that results from <strong>overdose</strong> or <strong>drug accumulation</strong>.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt;">d. Allergic reaction:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"><br>An <strong>allergic reaction</strong> is a <strong>hypersensitivity</strong> reaction triggered by the immune system in response to a drug. While it can be unexpected, it is not synonymous with an <strong>adverse effect</strong> because it involves an <strong>immune-mediated</strong> response, not a harmful or unintended drug effect.</span></li></ul></ol></li></ul></div></div>
            <div class="question">
                <h3>Question No: 8</h3>
                <p><b>In the context of the medicine verification “Two/Double-check” method followed by two nurses, which drug needs to be checked by two nurses?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Ibuprofen</li><li>2. Amoxicillin</li><li>3. Heparin</li><li>4. Acetaminophen</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 36.0pt; line-height: normal;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Heparin</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"> is a <strong>high-risk medication</strong> that requires careful dosing and monitoring due to its potential to cause severe complications, such as <strong>bleeding</strong> and <strong>heparin-induced thrombocytopenia (HIT)</strong>. For this reason, the <strong>"Two/Double-check" method</strong> is often employed, where two nurses independently verify the <strong>dose</strong>, <strong>route</strong>, and <strong>patient identity</strong> before administration. This process reduces the risk of medication errors, which are particularly critical for anticoagulants like <strong>heparin</strong>.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 36.0pt; line-height: normal;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Distractors:</span></strong></p><ol start="1" type="1"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">A: Ibuprofen:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Ibuprofen</strong> is an <strong>NSAID</strong> used for pain and inflammation. While it requires caution in patients with certain conditions (e.g., <strong>renal disease</strong>, <strong>ulcers</strong>), it is <strong>not classified as a high-risk drug</strong> requiring a <strong>double-check</strong> procedure by two nurses.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">B: Amoxicillin:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Amoxicillin</strong> is an <strong>antibiotic</strong> and is generally not considered a <strong>high-risk medication</strong> that mandates a <strong>double-check</strong> by two nurses. However, it still requires proper verification, especially in terms of <strong>dose</strong> and <strong>allergy status</strong>.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">D: Acetaminophen:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Acetaminophen</strong> (paracetamol) is generally <strong>safe at therapeutic doses</strong>, but excessive doses can lead to <strong>liver damage</strong>. While caution is necessary, it is <strong>not routinely verified by two nurses</strong> unless the <strong>dose</strong> is particularly high (e.g., in overdose cases or when used in combination with other medications).</span></li></ul></ol><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Clinical Application:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br>For high-risk medications such as <strong>heparin</strong>, implementing the <strong>two-nurse verification method</strong> enhances patient safety by minimizing the risk of errors during administration. This method ensures that the correct drug, dose, and patient are matched and helps prevent serious medication errors.</span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 9</h3>
                <p><b>A patient has been using opioids for a long time but has discontinued them. The nurse anticipates the use of which drug to prevent and reduce opioid relapse?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Acomprosate</li><li>2. Disulfiram</li><li>3. Buprenorphine</li><li>4. Haloperidol</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 36.0pt; line-height: normal;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Buprenorphine</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"> is a <strong>partial agonist</strong> at the opioid receptor and is commonly used in the treatment of <strong>opioid dependence</strong>. It helps to <strong>prevent withdrawal symptoms</strong> and <strong>reduce cravings</strong>, making it a first-line treatment for preventing opioid relapse. It can also be used as part of <strong>opioid substitution therapy (OST)</strong>, helping to prevent <strong>relapse</strong> by stabilizing the patient and reducing cravings for opioids.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 36.0pt; line-height: normal;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Distractors:</span></strong></p><ol start="1" type="1"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">A: Acamprosate:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Acamprosate</strong> is used primarily for the treatment of <strong>alcohol dependence</strong>. It works by restoring the balance of certain neurotransmitters in the brain and is <strong>not effective for opioid dependence</strong>.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">B: Disulfiram:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Disulfiram</strong> is also used in the management of <strong>alcohol use disorder</strong>, as it causes unpleasant reactions (such as <strong>nausea</strong>, <strong>flushing</strong>, <strong>tachycardia</strong>) when alcohol is consumed. It is <strong>not used</strong> for opioid dependence.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">D: Haloperidol:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Haloperidol</strong> is an <strong>antipsychotic</strong> used to treat <strong>psychosis</strong> or <strong>agitation</strong> but has no role in preventing or reducing <strong>opioid relapse</strong>.</span></li></ul></ol><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Clinical Application:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br>For patients who have stopped using opioids and need support to prevent relapse, <strong>buprenorphine</strong> is a key drug to help manage withdrawal symptoms, cravings, and reduce the risk of relapse. It is often used alongside <strong>counseling and behavioral therapy</strong> in comprehensive addiction treatment plans.</span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 10</h3>
                <p><b>A patient is on MAOI inhibitors and presents with confusion, agitation, and fever. This side effect is called?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Neuroleptic malignant syndrome</li><li>2. Hypertensive crisis</li><li>3. Fever and chills</li><li>4. Nausea and vomiting</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoListParagraph" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; mso-add-space: auto; text-indent: -18.0pt; line-height: normal; mso-list: l1 level1 lfo1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-language: EN-IN;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Monoamine oxidase inhibitors (MAOIs)</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"> can cause a <strong>hypertensive crisis</strong> when taken with certain foods (like aged cheese, cured meats) or other medications that contain <strong>tyramine</strong>. This occurs due to the accumulation of <strong>monoamines</strong> like <strong>norepinephrine</strong>, leading to <strong>severe hypertension</strong>, along with symptoms like <strong>confusion</strong>, <strong>agitation</strong>, <strong>fever</strong>, and <strong>headache</strong>. A hypertensive crisis can be <strong>life-threatening</strong> if not treated promptly.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Distractors:</span></strong></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 36.0pt; text-indent: -18.0pt; line-height: normal; mso-list: l0 level2 lfo2;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-language: EN-IN;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">A: Neuroleptic malignant syndrome:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Neuroleptic malignant syndrome (NMS)</strong> is a <strong>rare, but serious condition</strong> typically caused by <strong>antipsychotic medications</strong> (especially <strong>dopamine antagonists</strong>), not MAOIs. Symptoms include <strong>hyperthermia</strong>, <strong>muscle rigidity</strong>, <strong>autonomic instability</strong>, and <strong>altered mental status</strong>.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 36.0pt; text-indent: -18.0pt; line-height: normal; mso-list: l0 level2 lfo2;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-language: EN-IN;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">C: Fever and chills:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br>While fever may occur as part of a <strong>hypertensive crisis</strong>, it is not typically associated with <strong>chills</strong> in this context. Chills are more commonly seen in <strong>infections</strong> or other inflammatory conditions.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 36.0pt; text-indent: -18.0pt; line-height: normal; mso-list: l0 level2 lfo2;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-fareast-language: EN-IN;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">D: Nausea and vomiting:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Nausea and vomiting</strong> can occur with many drug side effects, including those related to <strong>MAOIs</strong> (especially if there is an interaction with <strong>tyramine</strong>). However, it is not the primary presentation associated with the combination of <strong>confusion</strong>, <strong>agitation</strong>, and <strong>fever</strong>.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal;"><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Clinical Application:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br>For patients on <strong>MAOIs</strong>, it is crucial to educate about <strong>dietary restrictions</strong> to avoid <strong>tyramine-rich foods</strong> and <strong>drug interactions</strong> that can precipitate a <strong>hypertensive crisis</strong>. Prompt management involves <strong>antihypertensive treatment</strong> and <strong>supportive care</strong>.</span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 11</h3>
                <p><b>Which drug is the first-line treatment for ventricular tachycardia (VT) and ventricular fibrillation (VFib)?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Lidocaine</li><li>2. Amiodarone</li><li>3. Digoxin</li><li>4. Verapamil</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p><strong>Rationale for the correct answer:</strong><br>Amiodarone is a potassium channel blocker that prolongs repolarization and stabilizes the cardiac membrane. It is the first-line drug for ventricular tachycardia (VT) and ventricular fibrillation (VFib) because of its effectiveness in terminating these life-threatening arrhythmias and preventing recurrence.</p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Rationale for the distractors:</span></strong></p><p class="MsoListParagraphCxSpFirst" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 54.0pt; mso-add-space: auto; text-align: justify; text-indent: -18.0pt; line-height: normal; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;">Lidocaine:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"> Lidocaine, a sodium channel blocker, is effective in certain types of ventricular arrhythmias, particularly those related to ischemia (e.g., myocardial infarction). However, it is not the first-line drug for VT/V Fib in the absence of specific conditions like myocardial infarction.</span></p><p class="MsoListParagraphCxSpMiddle" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 54.0pt; mso-add-space: auto; text-align: justify; text-indent: -18.0pt; line-height: normal; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;">Digoxin:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"> Digoxin is used primarily for controlling heart rate in atrial fibrillation but does not have a role in the acute management of VT or V Fib.</span></p><p class="MsoListParagraphCxSpLast" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 54.0pt; mso-add-space: auto; text-align: justify; text-indent: -18.0pt; line-height: normal; mso-list: l0 level1 lfo1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;">Verapamil:</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"> Verapamil, a calcium channel blocker, is effective in treating supraventricular tachycardia but is contraindicated in ventricular arrhythmias like VT and V Fib due to its potential to worsen the condition by causing hypotension or cardiac arrest.</span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 12</h3>
                <p><b>An adult is being treated with isoniazid (INH) and streptomycin for active tuberculosis. Which of the following symptoms would suggest a toxic effect of INH?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Paroxysmal tachycardia</li><li>2. Erythema multiform</li><li>3. Peripheral neuritis</li><li>4. Tinnitus and deafness</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p style="line-height: 115%;"><strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">Isoniazid (INH)</span></strong> is associated with the development of <strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">peripheral neuritis</span></strong> due to its interference with <strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">vitamin B6 (pyridoxine) metabolism</span></strong>. INH inhibits the activation of pyridoxine, which is crucial for nerve function, leading to nerve damage, presenting as tingling, numbness, and burning in the extremities. This side effect can be prevented by supplementing the patient with pyridoxine during INH therapy.</p><h3 style="line-height: 115%;"><span style="font-size: 12.0pt; line-height: 115%;">Distractors:</span></h3><p style="line-height: 115%;">a) <strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">Paroxysmal tachycardia</span></strong> &ndash; While INH can cause various side effects, it is not typically associated with causing heart issues like paroxysmal tachycardia. This symptom is more related to cardiac or autonomic system disturbances, not INH toxicity.</p><p style="line-height: 115%;">b) <strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">Erythema multiform</span></strong> &ndash; This is a rare hypersensitivity reaction to drugs or infections. Although some antimicrobials can cause it, it is not a typical toxic effect of INH.</p><p class="MsoNormal"><span lang="EN-US" style="font-size: 12.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">d) <strong>Tinnitus and deafness</strong> &ndash; These symptoms are commonly associated with <strong>streptomycin</strong>, an aminoglycoside that can cause <strong>ototoxicity</strong>. However, they are not related to INH toxicity. </span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 13</h3>
                <p><b>What is the recommended dose of Levonorgestrel for emergency contraception?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 1 mg single dose within 3 days</li><li>2. 0.75 mg two tablets 12 hours apart</li><li>3. 30 mg single tablet within 5 days</li><li>4. 600 mg single tablet within 3 days</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li><strong>Levonorgestrel</strong> is the drug of choice (DOC) for emergency contraception. The recommended dosage is 0.75 mg taken as two tablets 12 hours apart or a single dose of 1.5 mg within 3 days of unprotected intercourse.</li></ul><p>Options A, C, and D are incorrect dosages for Levonorgestrel. Option C refers to Ulipristal, while option D refers to Mifepristone.</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 14</h3>
                <p><b>What is the most common side effect associated with inhaled corticosteroids (ICS)?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Bronchospasm</li><li>2. Oropharyngeal candidiasis</li><li>3. Dry mouth</li><li>4. Weight gain</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">Oropharyngeal candidiasis </span></strong><em><strong style="mso-bidi-font-weight: normal;">Correct</strong>:</em> Oropharyngeal candidiasis, also known as <strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">thrush</span></strong>, is the most common side effect associated with inhaled corticosteroids. This occurs due to the local immunosuppressive effects of corticosteroids in the oral cavity, leading to <strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">fungal overgrowth</span></strong>. Rinsing the mouth after inhalation can help reduce this risk.</p><p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">Bronchospasm </span></strong><em>Incorrect:</em> Bronchospasm is not a common side effect of inhaled corticosteroids. In fact, ICS are used to <strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">reduce inflammation</span></strong> and prevent bronchospasm in asthma patients. If bronchospasm occurs, it is more likely related to inadequate bronchodilation or an allergic reaction.</p><p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">Dry mouth </span></strong><em>Incorrect:</em> While dry mouth can occur, it is <strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">not the most common side effect</span></strong> of ICS. This side effect is more frequently associated with anticholinergic medications rather than corticosteroids.</p><p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">Weight gain </span></strong><em>Incorrect:</em> Weight gain is typically associated with systemic corticosteroids rather than inhaled forms. ICS generally have a lower risk of causing weight gain due to their local effect rather than systemic absorption.</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 15</h3>
                <p><b>Which of the following is considered the drug of choice (DOC) for treating peptic ulcer disease (PUD)?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Ranitidine</li><li>2. Omeprazole</li><li>3. Sucralfate</li><li>4. Metoclopramide</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">a) Ranitidine</span></strong></p><ul type="disc"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt;">Incorrect.</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"> Ranitidine is an H2 receptor antagonist that decreases gastric acid secretion. While it is effective for managing PUD, it is not considered the first-line treatment compared to proton pump inhibitors (PPIs) like omeprazole. Studies have shown that PPIs provide better ulcer healing rates and symptom relief.</span></li></ul></ul><p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">b) Omeprazole</span></strong></p><ul type="disc"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt;">Correct.</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"> Omeprazole is a proton pump inhibitor (PPI) that inhibits the H+/K+ ATPase enzyme in the gastric parietal cells, effectively reducing gastric acid secretion. It is the DOC for PUD due to its superior efficacy in promoting ulcer healing, particularly in H. pylori eradication regimens, and managing acid-related disorders like gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome.</span></li></ul></ul><p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">c) Sucralfate</span></strong></p><ul type="disc"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt;">Incorrect.</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"> Sucralfate is a mucosal protective agent that acts by forming a viscous gel in the stomach, adhering to ulcer sites and protecting them from acid and pepsin. While it can aid in ulcer healing, it is not considered the first-line treatment or the DOC for PUD and is often used as an adjunctive therapy.</span></li></ul></ul><p style="margin-left: 36.0pt; text-indent: -18.0pt; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 12.0pt; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="mso-fareast-font-family: 'DengXian Light'; mso-fareast-theme-font: major-fareast;">d) Metoclopramide</span></strong></p><ul type="disc"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: normal; mso-list: l0 level2 lfo1; tab-stops: list 72.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt;">Incorrect.</span></strong><span lang="EN-US" style="font-size: 12.0pt; font-family: 'Times New Roman',serif;"> Metoclopramide is a prokinetic agent that enhances gastrointestinal motility and gastric emptying but does not directly address gastric acid secretion. It is not indicated as a primary treatment for PUD and is mainly used for conditions like gastroparesis or as an antiemetic.</span></li></ul></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 16</h3>
                <p><b>The nurse is teaching a patient to self-administer insulin. The instructions should include teaching the patient to:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Inject the needle at a 45° angle into the muscle</li><li>2. Rotate injection sites</li><li>3. Vigorously massage the area after injection</li><li>4. All of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Injection sites should be rotated to prevent tissue damage or lipodystrophy. Insulin is injected at a 90° angle into the deep subcutaneous tissue, not 45° angle into the muscle. </li><li>Vigorously massaging the injection site is not advised.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 17</h3>
                <p><b>The characteristic and common presentation of diabetic neuropathy is:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Amyotrophy</li><li>2. Mononeuropathy</li><li>3. Symmetrical sensory neuropathy</li><li>4. Autonomic neuropathy</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>The most common form of diabetic neuropathy is distal symmetric sensory polyneuropathy.</li><li>It most frequently presents with distal sensory loss.</li><li>Symmetrical sensory neuropathy is the most characteristic and common presentation of diabetic neuropathy. It typically affects the feet and hands in a symmetrical pattern, leading to symptoms like numbness, tingling, pain, or a loss of sensation. This type of neuropathy is often seen in individuals with long-term diabetes.</li><li>Other types of neuropathy (e.g., amyotrophy, mononeuropathy, and autonomic neuropathy) can also occur in diabetic patients but are less common compared to symmetrical sensory neuropathy.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 18</h3>
                <p><b>All of the following are the clinical manifestation of diabetes mellitus, except:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Glycosuria</li><li>2. Hyperglycemia</li><li>3. Hypoglycemia</li><li>4. Polyuria</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The most common diabetes signs and symptom include frequent urination (polyuria), presence of glucose in urine (glycosuria), increased blood sugar (hyperglycemia), intense thirst and hunger, weight gain, unusual weight loss, fatigue, cuts and bruises that do not heal, male sexual dysfunction, numbness and tingling, hands and feet. Hypoglycemia is not a feature of diabetes mellitus.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 19</h3>
                <p><b>Which of the following is not a test for diabetes mellitus?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Fasting blood glucose</li><li>2. Random blood glucose</li><li>3. D-Xylose test</li><li>4. Oral glucose tolerance test</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>D-Xylose test is test for assent of proximal small intestinal mucosal function. D- Xylose test is used to assess carbohydrate malabsorption and is not a test for assessment of diabetes mellitus.</li><li>Fasting blood glucose, random blood glucose and oral glucose tolerance test are all used for assessment of diabetes mellitus.</li></ul><p><b> Criteria for the diagnosis of diabetes mellitus</b><ul ><li>Symptoms of diabetes plus random blood glucose concentration > 111.1 mmol/L (200 mg/dL) or</li><li>Fasting plasma glucose 270 mmol/L (126 mg/dL) or</li><li>Two-hour plasma glucose > 11.1 mmol/L (200 mg/dL) during an oral glucose tolerance test. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 20</h3>
                <p><b>The client’s breath having a “fruity” odor is suggestive of:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Albuminuria</li><li>2. Ketoacidosis</li><li>3. Acidity</li><li>4. Proteinuria</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Ketoacidosis is a complication seen in patients with Diabetes Mellitus in which ketone bodies are formed, giving a fruity odor to patient’s breath. These ketone bodies are produced because of excessive accumulation of glucose due to less amount of insulin in blood. </li><li>Albuminuria is a condition in which albumin (protein) is present in the urine caused by impaired renal functions. This does not give a fruity smell to breath. </li><li>Acidity is a gastrointestinal problem caused by excessive production of acid in the stomach. </li><li>Proteinuria is synonymous to albuminuria. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 21</h3>
                <p><b>Negative symptoms in schizophrenia include all, except:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Avolition</li><li>2. Alogia</li><li>3. Anhedonia</li><li>4. Anomie</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>Anomie is not a feature of schizophrenia. Anomie is a term used in sociology to describe a breakdown of social norms or a state of normlessness and is not typically associated with schizophrenia or its symptoms.</li><li>Symptoms of schizophrenia can be classified as positive or negative.</li><li>Anything abnormal added to a patient&rsquo;s life is a positive symptom and anything normal lost from a patient&rsquo;s life is a negative symptom.</li><li>Alogia: poverty of speech</li><li>Avolition: apathy</li><li>Attention (poor)</li></ul><p><strong>Table:</strong> Symptoms of schizophrenia</p><table style="border-collapse: collapse; width: 99.9979%;" border="1"><colgroup><col style="width: 49.9825%;"><col style="width: 49.9825%;"></colgroup><tbody><tr><td style="width: 190.95pt; border: solid black 1.0pt; mso-border-alt: solid black .5pt; background: yellow; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="255"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal;"><strong style="mso-bidi-font-weight: normal;"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">Positive symptoms</span></strong></p></td><td style="width: 222.95pt; border: solid black 1.0pt; border-left: none; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; background: yellow; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="297"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal;"><strong style="mso-bidi-font-weight: normal;"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">Negative symptoms</span></strong></p></td></tr><tr><td style="width: 190.95pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="255"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal;"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">Hallucination Delusion Bizarre motor acts </span></p></td><td style="width: 222.95pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="297"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal;"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">Flattening of affect Anhedonia Alogia Apathy Paucity of thought Poverty of speech</span></p></td></tr><tr><td style="width: 190.95pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="255"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal;"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">Common in acute schizophrenia</span></p></td><td style="width: 222.95pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="297"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal;"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">Common in chronic schizophrenia</span></p></td></tr><tr><td style="width: 190.95pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="255"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal;"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">Hyperactivity of the dopaminergic system in the mesolimbic system</span></p></td><td style="width: 222.95pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="297"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal;"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">Hypoactivity of the dopaminergic system in the mesocortical system</span></p></td></tr><tr><td style="width: 190.95pt; border: solid black 1.0pt; border-top: none; mso-border-top-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="255"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal;"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">Respond to most typical and atypical</span></p></td><td style="width: 222.95pt; border-top: none; border-left: none; border-bottom: solid black 1.0pt; border-right: solid black 1.0pt; mso-border-top-alt: solid black .5pt; mso-border-left-alt: solid black .5pt; mso-border-alt: solid black .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="297"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal;"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">Respond better to atypical antipsychotics</span></p></td></tr></tbody></table></li></ul></div></div>
            <div class="question">
                <h3>Question No: 22</h3>
                <p><b>A 45-year-old male presented to the psychiatry OPD with the clinical features of speaking to himself, hearing two people talk about him, reduced affect and impaired judgment which were present for more than 6 months. What is your diagnosis?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Schizophreniform disorder</li><li>2. Schizoaffective disorder</li><li>3. Schizophrenia</li><li>4. Schizoid personality disorder OM</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoNormal" style="margin-left: 18.0pt; text-indent: -18.0pt; line-height: 106%; mso-list: l1 level1 lfo1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: 'Times New Roman',serif;">The patient has auditory hallucination, reduced affect, lack of insight, impaired judgment for more than 6 months, which is suggestive of schizophrenia. </span></p><p class="MsoNormal" style="margin-left: 18.0pt; text-indent: -18.0pt; line-height: 106%; mso-list: l1 level1 lfo1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: 'Times New Roman',serif;">If a <strong style="mso-bidi-font-weight: normal;">schizophrenia presentation has not been present for 6 months, think schizophreniform disorder</strong>. The diagnosis of schizophreniform disorder is made using the same DSM-5 criteria as schizophrenia. The only difference between the two is that in schizophreniform disorder the symptoms have lasted between 1 and 6 months, whereas in schizophrenia the symptoms must be present for &gt; 6 months.</span></p><p class="MsoNormal" style="margin-left: 18.0pt; text-indent: -18.0pt; line-height: 106%; mso-list: l1 level1 lfo1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong style="mso-bidi-font-weight: normal;"><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: 'Times New Roman',serif;">The diagnosis of schizoaffective disorder is made in patients who:</span></strong></p><p class="MsoNormal" style="margin-left: 72.0pt; text-indent: -18.0pt; line-height: 106%; mso-list: l0 level1 lfo2;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New';"><span style="mso-list: Ignore;">o<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: 'Times New Roman',serif;">Meet criteria for either a major depressive or manic episode during which psychotic symptoms consistent with schizophrenia are also met.</span></p><p class="MsoNormal" style="margin-left: 72.0pt; text-indent: -18.0pt; line-height: 106%; mso-list: l0 level1 lfo2;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New';"><span style="mso-list: Ignore;">o<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: 'Times New Roman',serif;">Delusions or hallucinations for 2 weeks in the absence of mood disorder symptoms (this criterion is necessary to differentiate schizoaffective disorder from mood disorder with psychotic features).</span></p><p class="MsoNormal" style="margin-left: 72.0pt; text-indent: -18.0pt; line-height: 106%; mso-list: l0 level1 lfo2;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New';"><span style="mso-list: Ignore;">o<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: 'Times New Roman',serif;">Mood symptoms present for a majority of the psychotic illness.</span></p><p class="MsoNormal" style="margin-left: 72.0pt; text-indent: -18.0pt; line-height: 106%; mso-list: l0 level1 lfo2;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New';"><span style="mso-list: Ignore;">o<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: 'Times New Roman',serif;">Symptoms not due to the effects of a substance (drug or medication) or another medical condition.</span></p><p class="MsoNormal" style="margin-left: 18.0pt; text-indent: -18.0pt; line-height: 106%; mso-list: l1 level1 lfo1;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 12.0pt; line-height: 106%; font-family: 'Times New Roman',serif;">Patients with schizoid personality disorder have a lifelong pattern of social withdrawal. They are often perceived as eccentric and reclusive. They are quiet and unsociable and have a constricted affect. They have no desire for close relationships and prefer to be alone.</span></p><p>&nbsp;</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 23</h3>
                <p><b>In Piaget’s theory of cognitive development, out of sight, out of mind is seen in which stage?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Pre operational</li><li>2. Sensorimotor</li><li>3. Concrete operational</li><li>4. Formal operational</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>According to the cognitive development stages described by Jean Piaget, the out of sight, out of mind type of thinking is present in the sensorimotor stage of cognitive development.</li><li>There are 4 stages in the cognitive development stages, through which the thinking process of an individual develops.</li></ul><p><strong>Table:</strong> Stages of Cognitive Development Stages</p><table style="border-collapse: collapse; width: 99.9979%;" border="1"><colgroup><col style="width: 49.9825%;"><col style="width: 49.9825%;"></colgroup><tbody><tr><td style="width: 193.6pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 104.65pt;" valign="top" width="258"><p class="MsoNormal" style="margin-bottom: 8.0pt; text-align: justify; line-height: 107%;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Sensorimotor stage (Birth - 2 years)</span></p></td><td style="width: 257.2pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 104.65pt;" valign="top" width="343"><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l2 level1 lfo1; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Starts with Out of sight, out of mind type of thinking</span></p><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l2 level1 lfo1; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Ends with object permanence (knowing an object exists even though it cannot be seen)</span></p><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l2 level1 lfo1; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; background: aqua; mso-highlight: aqua; mso-font-kerning: 0pt; mso-ligatures: none;">Symbolization-</span><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Developing mental symbol and words for the objects. </span></p></td></tr><tr><td style="width: 193.6pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 104.65pt;" valign="top" width="258"><p class="MsoNormal" style="margin-bottom: 8.0pt; text-align: justify; line-height: 107%;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Pre-operational Stage (2 - 7 years)</span></p></td><td style="width: 257.2pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 104.65pt;" valign="top" width="343"><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l0 level1 lfo2; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Thinking without reasoning-Intuitive thinking</span></p><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l0 level1 lfo2; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Only concerned about their own needs and perspective-egocentric thinking</span></p><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l0 level1 lfo2; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Other thinking processes are seen-animism, primitive thinking, centration, magical or fantasy thinking </span></p></td></tr><tr><td style="width: 193.6pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 184.9pt;" valign="top" width="258"><p class="MsoNormal" style="margin-bottom: 8.0pt; text-align: justify; line-height: 107%;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Concrete operational (7 - 11 years)</span></p></td><td style="width: 257.2pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 184.9pt;" valign="top" width="343"><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l3 level1 lfo3; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Starts to see things from other&rsquo;s perspective</span></p><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l3 level1 lfo3; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Thinking is concentrated and literal </span></p><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l3 level1 lfo3; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Develop conservation-understanding that despite changes in shape, he object remains the same. For e.g. When water is transferred from a cup to glass, they understand that it is water only and that the volume is the same.</span></p><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l3 level1 lfo3; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Develop the concept of reversibility-knowing that one thing can turn into another and turn back. E.g. Water and ice.</span></p><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l3 level1 lfo3; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Other processes - Clarification</span></p></td></tr><tr><td style="width: 193.6pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 64.25pt;" valign="top" width="258"><p class="MsoNormal" style="margin-bottom: 8.0pt; text-align: justify; line-height: 107%;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Formal operational (&gt; 11 years)</span></p></td><td style="width: 257.2pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt; height: 64.25pt;" valign="top" width="343"><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l1 level1 lfo4; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Develop abstract thinking, wherein they can generalize or conceptualize</span></p><p class="MsoNormal" style="text-align: justify; text-indent: -18.0pt; line-height: 107%; mso-list: l1 level1 lfo4; margin: 0cm 0cm 8.0pt 18.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-font-kerning: 0pt; mso-ligatures: none;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif; mso-font-kerning: 0pt; mso-ligatures: none;">Can make a hypothesis and use deductive reasoning </span></p></td></tr></tbody></table></li></ul></div></div>
            <div class="question">
                <h3>Question No: 24</h3>
                <p><b>The condition in which false beliefs are firmly maintained even though they are not shared by others is called:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Delirium</li><li>2. Hallucination</li><li>3. Delusion</li><li>4. Illusion</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Delusion is a false unshakeable belief which is not amenable to reasoning and is not in keeping with the patient’s socio-cultural and educational background.</li><li>Delirium is a state of mental confusion and excitement that happens in a short period of time and is characterized by disorientation for time and place, usually with illusions and hallucinations.</li><li>Hallucination is a false sensory perception in the absence of actual external stimulus.</li><li>Illusion is the misinterpretation of a real, external sensory experience. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 25</h3>
                <p><b>The period of normalcy is seen between two psychosis. The diagnosis is:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Schizophrenia</li><li>2. Manic depressive psychosis</li><li>3. Alcoholism</li><li>4. Depression</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Manic depressive psychosis was the older name for bipolar disorder.</li><li>In bipolar disorder, in between the episodes, patient is usually normal.</li><li>Bipolar disorder:</b> Episodes of - both mania (continuing or at least 1 week) and Depression (bipolar 1 disorder). </li><li>Both hypomania (continuing or at least 4 days) and depression (bipolar II disorder). </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 26</h3>
                <p><b>Persistent feeling of guilt is seen in:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Obsessive compulsive disorder</li><li>2. Mania</li><li>3. Depression</li><li>4. Schizophrenia</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><b>Symptoms of depression:</b> <ul ><li></li><li><b>SWAG</b> (Suicidality, weight loss, anhedonia and guilt feelings) is quite suggestive of depression. </li><li><b>Suicidal thoughts</b> and sadness of mood (depressed mood).</li><li><b>Appetite:</b> Usually the appetite and weight are lost; in some patient weight gain may be seen. </li><li><b>Interest (Loss):</b> Patient losses interest in the activities which is used to interest him earlier (Anhedonia).</li><li><b>Guilt:</b> Patient may have excessive guilt feelings and may blame himself for trivial matters. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 27</h3>
                <p><b>Nurse Rica is teaching a patient and her family about the causes of depression. Which of the following causative factors should the nurse emphasize as the most significant?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Brain structure abnormalities</li><li>2. Chemical imbalance</li><li>3. Social environment</li><li>4. Recessive gene transmission</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Chemical imbalance of neurotransmitters in the brain is the most significant factor in depression. </li><li>However, the exact cause has not been established, so other factors may also be involved. The underlying pathophysiology of major depressive disorder has not been clearly defined. </li><li>Current evidence points to a complex interaction between neurotransmitter availability and receptor regulation and sensitivity underlying the affective symptoms.</li><li><b>Option A:</b> Vascular lesions may contribute to depression by disrupting the neural networks involved in emotion regulation—in particular, front striatal pathways that link the dorsolateral prefrontal cortex, orbitofrontal cortex, anterior cingulate, and dorsal cingulate. Other components of limbic circuitry, in particular, the hippocampus and amygdala, have been implicated in depression.</li><li><b>Option C:</b> A person’s social environment, including lack of support systems, may also increase the risk of depression. The etiology of major depressive disorder is multifactorial with both genetic and environmental factors playing a role. First-degree relatives of depressed individuals are about 3 times as likely to develop depression as the general population; however, depression can occur in people without family histories of depression. </li><li><b>Option D:</b> Although genetic transmission certainly may be a factor, no definite pattern of transmission has been identified. Some evidence suggests that genetic factors play a lesser role in late-onset depression than in early-onset depression. There are potential biological risk factors that have been identified for depression in the elderly.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 28</h3>
                <p><b>The cognitive triad of depression, negative views of self, the world, and future, was explained by __________.</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Aron Beck</li><li>2. Frankl</li><li>3. Joseph Wolpe</li><li>4. Winnicott</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>The cognitive triad of depression, negative views of self, the world, and future, was explained by Aron Beck in 1976. It is also known as &ldquo;negative triad&rdquo; or &ldquo;Beck&rsquo;s triad&rdquo; and is used to display the belief system of the person with depression. It is displayed as:</li></ul><p><img title="image001.jpg" src="data:image/jpeg;base64,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" alt="" width="300" height="181"></p><ul><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 29</h3>
                <p><b>Nurse Rosy is caring for a client with depression who has not responded to antidepressant medication. The nurse anticipates what treatment procedure may be prescribed?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Neuroleptic medication</li><li>2. Short term seclusion</li><li>3. Psychosurgery</li><li>4. Electroconvulsive therapy</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Electroconvulsive therapy is an effective treatment for depression that has not responded to medication. Electroconvulsive therapy (ECT) uses an electric current to create a generalized cerebral seizure. Although it is primarily utilized to treat patients with severe depression, patients with schizophrenia, schizoaffective disorder, catatonia, neuroleptic malignant syndrome, and bipolar disorder may also benefit.</li><li><b>Option A:</b> Neuroleptics, also known as antipsychotic medications, are used to treat and manage symptoms of many psychiatric disorders. They fall into two classes, i.e. first-generation or “typical” antipsychotics and second-generation or “atypical” antipsychotics.”</li><li><b>Option B:</b> Seclusion is the formal placing of a patient in a specially designated room for the short-term management of disturbed/violent behavior. Indications for seclusion include:</b> to prevent imminent harm to others, namely staff, and other patients, if other means are inappropriate or ineffective.</li><li><b>Option C:</b> Psychosurgery is a field of surgery which consists of stereotactic operations on the brain aimed at altering abnormal physiology by severing certain connections between the frontal lobe and the rest of the brain, including the cortex, the nuclei, or other brain pathways, which may appear to function normally or abnormally, in order to reduce mental and/or physical suffering in otherwise untreatable patients.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 30</h3>
                <p><b>Five months after the incident the patient complains of difficulty to concentrate, poor appetite, inability to sleep and guilt. She is likely suffering from:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Adjustment disorder</li><li>2. Somatoform Disorder</li><li>3. Generalized Anxiety Disorder</li><li>4. Post-traumatic stress disorder</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Post-traumatic stress disorder is characterized by flashbacks, irritability, and difficulty falling asleep, and concentrating following an extremely traumatic event. This lasts for more than one month. </li><li>Posttraumatic stress disorder (PTSD) is a syndrome that results from exposure to real or threatened death, serious injury, or sexual assault. Following the traumatic event, PTSD is common and is one of the serious health concerns that is associated with comorbidity, functional impairment, and increased mortality with suicidal ideations and attempts.</li><li><b>Option A:</b> Adjustment disorder is the maladaptive reaction to stressful events characterized by anxiety, depression, and work or social impairments. This occurs within three (3) months after the event. Adjustment disorders involve markedly distressing and impairing emotional and/or behavioral symptoms caused by an identifiable stressor.</li><li><b>Option B:</b> Somatoform disorders are anxiety-related disorders characterized by the presence of physical symptoms without a demonstrable organic basis. The somatoform disorders are a group of psychiatric disorders in which patients present with a myriad of clinically significant but unexplained physical symptoms. They include somatization disorder, undifferentiated somatoform disorder, hypochondriasis, conversion disorder, pain disorder, body dysmorphic disorder, and somatoform disorder not otherwise specified.</li><li><b>Option C:</b> Generalized anxiety disorder is characterized by chronic, excessive anxiety for at least 6 months. Generalized anxiety disorder is one of the most common mental disorders. Up to 20% of adults are affected by anxiety disorders each year. Generalized anxiety disorder produces fear, worry, and a constant feeling of being overwhelmed.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 31</h3>
                <p><b>Doing repetitive rituals or movements is associated with______ disease.</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Acute stress disorder</li><li>2. Generalized anxiety disorder</li><li>3. Dissociative disorder</li><li>4. Obsessive compulsive disorder</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li><strong>Acute stress disorder </strong>is an intense, unpleasant, and dysfunctional reaction beginning shortly after an overwhelming traumatic event and lasting less than a month.</li><li><strong>Generalized Anxiety Disorder (GAD)</strong> is characterized by persistent and excessive worry about a number of different things.</li></ul><p>Dissociative disorders are mental disorders that involve experiencing a disconnection and lack of continuity between thoughts, memories, surroundings, actions and identity.</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 32</h3>
                <p><b>Which of the following is NOT a common symptom of Generalized Anxiety Disorder (GAD)?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Difficulty concentrating</li><li>2. Muscle tension</li><li>3. Avoidance of specific situations</li><li>4. Sleep disturbances</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p>Avoidance of specific situations is more characteristic of specific phobias or social anxiety disorder, not GAD. Individuals with GAD worry about a variety of situations but do not necessarily avoid them.</p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 18.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 107%;">a) Difficulty concentrating</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 107%; font-family: 'Times New Roman',serif;"><br><strong>Rationale:</strong> Difficulty concentrating is common in GAD. Worry can make it difficult for individuals to focus or complete tasks.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 18.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 107%;">b) Muscle tension</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 107%; font-family: 'Times New Roman',serif;"><br><strong>Rationale:</strong> Muscle tension is another physical symptom frequently seen in people with GAD due to the chronic state of anxiety.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 18.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 107%;">c) Avoidance of specific situations</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 107%; font-family: 'Times New Roman',serif;"><br><strong>Rationale:</strong> Avoidance is more characteristic of specific phobias or social anxiety disorder, not GAD, where worry is pervasive across many situations, but avoidance is not a primary feature.</span></p><p class="MsoNormal" style="padding-left: 40px;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 107%;">d) Sleep disturbances</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 107%; font-family: 'Times New Roman',serif;"><br><strong>Rationale:</strong> Sleep disturbances, such as difficulty falling asleep or staying asleep, are common in GAD because anxiety often interferes with relaxation.<span style="mso-spacerun: yes;">&nbsp; </span></span></p><p>&nbsp;</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 33</h3>
                <p><b>A patient admitted in the ICU for severe pneumonia 5 days ago now presents suddenly with failure to recognize his relatives and the doctor mutters that he is in jail. He is in an altered sensorium. This condition is __________:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Acute dementia</li><li>2. Brief psychotic reaction</li><li>3. ICU psychosis</li><li>4. Acute paranoia</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>The given clinical features point to diagnosis of ICU psychosis (delirium). The following features are consistent with the diagnosis of delirium:</b> <ul ><li> The patient is in the ICU (Delirium - ICU Psychosis) </li><li>There is an acute onset of symptoms. </li><li>He is disoriented to place - Jail instead of hospital. </li><li>He is disoriented to persons - Failure to recognize relatives and the doctor. </li><li>He is in altered sensorium.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 34</h3>
                <p><b>The new terminologies introduced by the “Mental Health Act”, 1987 are all, EXCEPT:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Asylum</li><li>2. Psychiatric hospital</li><li>3. Mentally ill person</li><li>4. Mentally ill prisoner</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Asylum is an old terminology which was replaced by psychiatric hospital or nursing homes by the Mental Health Act, 1987.</li><li>Other options are incorrect as these all are the new terminologies.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 35</h3>
                <p><b>A nurse administers 100% oxygen to a client during and after electroconvulsive therapy (ECT). What is the nurse rationale for this procedure?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. To prevent increased intracranial pressure (ICP) resulting from hypoxia</li><li>2. To prevent hypotension, bradycardia, and bradypnea due to electrical stimulation</li><li>3. To prevent anoxia due to medical-induced paralysis of respiratory muscles.</li><li>4. To prevent blocked airway resulting from seizure activity.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The nurse administers oxygen to a client during and after ECT to prevent anoxia due to medical-induced paralysis of respiratory muscles. In a patient under intravenous sedation or general anesthesia, electroconvulsive therapy (ECT) uses an electric current to create a generalized cerebral seizure. Once the patient is unconscious, administration of a muscle relaxant follows, along with bag valve mask ventilation with 100 % oxygen. <b>Hence, option c. is correct.</b></li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 36</h3>
                <p><b>An alcoholic lady is on disulfiram therapy and when she drinks wine she experiences nausea, vomiting, and restlessness. This is considered as:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Disulfiram-ethanol reaction</li><li>2. Allergic reaction</li><li>3. Side effects of disulfiram</li><li>4. Symptoms of withdrawal</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p>In normal case, the enzyme alcohol dehydrogenase (ALDH) in the liver and brain transforms alcohol into acetaldehyde. ALDH also in the liver and brain, oxidizes the acetaldehyde by-product into acetic acid. Disulfiram blocks this oxidation by inhibiting ALDH, causing a rapid rise of acetaldehyde in the blood when alcohol is consumed. The result is called a disulfiram-alcohol reaction. The reaction usually begins about 10 to 30 minutes after alcohol is ingested.</p><p><strong>Table:</strong> Possible Effects of the Disulfiram-Alcohol Reaction</p><table style="border-collapse: collapse; width: 99.9979%;" border="1"><colgroup><col style="width: 33.3217%;"><col style="width: 33.3217%;"><col style="width: 33.3217%;"></colgroup><tbody><tr><td style="border: solid #DDDDDD 1.0pt; mso-border-alt: solid #DDDDDD .75pt; background: #F0F0F0; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><strong><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Body Part Affected</span></strong></p></td><td style="border: solid #DDDDDD 1.0pt; border-left: none; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; background: #F0F0F0; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><strong><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Moderate</span></strong></p></td><td style="border: solid #DDDDDD 1.0pt; border-left: none; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; background: #F0F0F0; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><strong><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Severe</span></strong></p></td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Body skin</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Sweating<br>Warmth and flushing, particularly on upper chest and face</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">None</span></p></td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" colspan="3" valign="top">&nbsp;</td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Respiratory system</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Hyperventilation<br>Respiratory difficulty/dyspnea</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Respiratory depression</span></p></td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" colspan="3" valign="top">&nbsp;</td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Head, neck, throat</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Acetaldehyde breath odor<br>Blurred vision<br>Head and neck throbbing<br>Thirst</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">None</span></p></td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" colspan="3" valign="top">&nbsp;</td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Stomach, digestive system</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Nausea/vomiting</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">None</span></p></td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" colspan="3" valign="top">&nbsp;</td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Chest, heart, circulatory system</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Chest pain/palpitations<br>Hypotension<br>Tachycardia</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Cardiovascular collapse<br>Arrhythmia<br>Myocardial infarction (in individuals with preexisting coronary artery disease)<br>Acute congestive heart failure (in individuals with preexisting myocardial dysfunction)</span></p></td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" colspan="3" valign="top">&nbsp;</td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Brain/ nervous system</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Vertigo<br>Syncope<br>Marked uneasiness<br>Confusion</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Seizures<br>Unconsciousness</span></p></td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" colspan="3" valign="top">&nbsp;</td></tr><tr><td style="border: solid #DDDDDD 1.0pt; border-top: none; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Other</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Weakness</span></p></td><td style="border-top: none; border-left: none; border-bottom: solid #DDDDDD 1.0pt; border-right: solid #DDDDDD 1.0pt; mso-border-top-alt: solid #DDDDDD .75pt; mso-border-left-alt: solid #DDDDDD .75pt; mso-border-alt: solid #DDDDDD .75pt; padding: 2.4pt 2.4pt 2.4pt 2.4pt;" valign="top"><p class="MsoNormal" style="margin-bottom: 16.6pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 107%; font-family: 'Times New Roman',serif;">Death</span></p></td></tr></tbody></table></li></ul></div></div>
            <div class="question">
                <h3>Question No: 37</h3>
                <p><b>With regards to diagnosis of Mental disorder, the term DSM stands for:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Disease System Manual</li><li>2. Diagnostic System manual</li><li>3. Diagnostic and Statistical Manual</li><li>4. Diagnostic System for mental disorder</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The Diagnostic and Statistical Manual of Mental Disorders (DSM) is the handbook used by health care professionals in the United States and much of the world as the authoritative guide to the diagnosis of mental disorders. DSM contains descriptions, symptoms, and other criteria for diagnosing mental disorders.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 38</h3>
                <p><b>Mr. Sudhir is experiencing alcohol withdrawal exhibits tremors, diaphoresis and hyperactivity. Blood pressure is 190/87 mmHg and pulse is 92 bpm. Which of the medications would the nurse expect to administer?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Naloxone (Narcan)</li><li>2. Benztropine (Cogentin)</li><li>3. Lorazepam (Ativan)</li><li>4. Haloperidol (Haldol)</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The nurse would most likely administer benzodiazepine, such as lorazepam (ativan) to the patient who is experiencing symptoms:</b> The patient experiences symptoms of withdrawal because of the rebound phenomenon when the sedation of the CNS from alcohol begins to decrease. </li><li>Lorazepam binds to benzodiazepine receptors on the postsynaptic GABA-A ligand-gated chloride channel neuron at several sites within the central nervous system (CNS). It enhances the inhibitory effects of GABA, which increases the conductance of chloride ions into the cell. This shift in chloride ions results in hyperpolarization and stabilization of the cellular plasma membrane. Its inhibitory action in the amygdala helps with anxiety disorders, while its inhibitory action in the cerebral cortex helps in seizure disorders.</li><li><b>Option A:</b> Naloxone is indicated for the treatment of opioid toxicity, specifically to reverse respiratory depression from opioid use. </li><li><b>Option B:</b> Benztropine belongs to the synthetic class of muscarinic receptor antagonists (anticholinergic drug). Thus, it has a structure similar to that of diphenhydramine and atropine. However, it is long-acting so that its administration has less frequency than diphenhydramine. It also induces less CNS stimulation effect compared to that of trihexyphenidyl, making it a preferable drug of choice for geriatric patients.</li><li><b>Option D:</b> Haloperidol is a first-generation (typical) antipsychotic medication that is used widely around the world. Food and Drug Administration (FDA) approved the use of haloperidol for schizophrenia, Tourette syndrome (control of tics and vocal utterances in adults and children), hyperactivity (which may present as impulsivity, difficulty maintaining attention, severe aggression, mood instability and frustration intolerance), severe childhood behavioral problems (such as combative, explosive hyperexcitability) and intractable hiccups. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 39</h3>
                <p><b>Priapism is treated with:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Phenylephrine</li><li>2. Sildenafil</li><li>3. Tadalafil</li><li>4. Vardenafil</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>Priapism is a prolonged erection of the penis. The full or partial erection continues hours beyond or isn&rsquo;t caused by sexual stimulation. The main types of priapism are ischemic and non-ischemic. Ischemic priapism is a medical emergency.</li><li><strong>Intracavernous injection:</strong> This treatment is used for low-flow priapism. Drugs known as alpha-agonists are injected into the penis. They cause narrowing of the arteries, reducing blood flow to the penis and causing the swelling to decrease.</li><li>A medication such as phenylephrine is used in priapism. This drug constricts blood vessels that carry blood into the penis. This action allows blood vessels that carry blood out of the penis to open up, increasing blood flow out of the penis.</li><li>For intracavernous injection of a sympathomimetic agent, the panel recommends the use of phenylephrine because this agent minimizes the risk of cardiovascular side effects that are more common for other sympathomimetic medications.</li><li>Sildenafil (Viagra) is used to treat erectile dysfunction (impotence; inability to get or keep an erection) in men.</li><li>Tadalafil is a medicine used to treat erection problems (erectile dysfunction) and symptoms of an enlarged prostate (benign prostate enlargement). It&rsquo;s also sometimes used to treat pulmonary hypertension (high blood pressure in the blood vessels that supply the lungs).</li><li>Vardenafil is in a class of medications called phosphodiesterase (PDE) inhibitors. It works by increasing blood flow to the penis during sexual stimulation. It is used to treat erectile dysfunction (impotence; inability to get or keep an erection) in men.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 40</h3>
                <p><b>Ms.Salima, 24 years old female comes with the complaint of binge eating followed by self-induced nausea and vomiting. What is the reason for this effect?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Fear of weight gain and becoming overweight</li><li>2. Binge eating gives pleasure</li><li>3. Thinking that binge eating has no health consequences</li><li>4. Binge eating occurs due to social pressure</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span lang="EN-US" style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">a. The pattern of binge eating followed by self-induced vomiting is characteristic of bulimia nervosa. Individuals with bulimia nervosa often have an intense fear of gaining weight and a distorted body image. This fear drives them to engage in compensatory behaviors, such as self-induced vomiting, to prevent weight gain after episodes of binge eating<span style="color: red;">.</span></span></p><p class="MsoNormal" style="text-align: justify; line-height: 150%;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">Rationale for other options:</span></strong></p><p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span lang="EN-US" style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">b. Binge eating gives pleasure: While binge eating can provide temporary relief or pleasure, it is typically followed by guilt, shame, and efforts to prevent weight gain, such as purging.</span></p><p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span lang="EN-US" style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">c. Thinking that binge eating has no health consequences: Individuals with bulimia nervosa are usually aware of the negative health consequences of their behavior but continue to engage in it due to their fear of weight gain and other psychological factors.</span></p><p class="MsoNormal" style="text-align: justify; line-height: 150%;"><span lang="EN-US" style="font-size: 12.0pt; line-height: 150%; font-family: 'Times New Roman',serif;">d. Binge eating occurs due to social pressure: Social pressure can contribute to disordered eating behaviors, but the specific cycle of binge eating followed by vomiting is primarily driven by the fear of weight gain and body image concerns.</span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 41</h3>
                <p><b>The nurse is caring for a terminally ill 58-year-old male client diagnosed with colon cancer. The client told the nurse that he does not want to continue his cancer treatment. The nurse communicated the client’s wishes to the primary healthcare provider (HCP). The nurse is conflicted because the client wants to discontinue the treatment, however, the healthcare provider does not. Which moral obligation should the nurse use to guide this client’s care?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. The nurse explains to the client that culture and traditions are providing incorrect guidance.</li><li>2. The nurse respects that the hospital has the final authority to make decisions for the client.</li><li>3. The nurse supports​ clients’ right to make their own healthcare decisions.</li><li>4. The nurse defends the choice to continue cancer therapy because that is what is best for the client.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%;"><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">The principle of <strong>autonomy</strong> in healthcare ethics emphasizes that clients have the right to make decisions about their own medical care, even if those decisions conflict with the opinions of healthcare providers or family members. Nurses are obligated to honor and advocate for their patients' choices, ensuring that they are informed and made without coercion. This approach respects the client's values, beliefs, and preferences.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-outline-level: 3;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Analysis of Distractors:</span></strong></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">a. The nurse explains to the client that culture and traditions are providing incorrect guidance: </span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">This response undermines the client&rsquo;s cultural and personal values, which are integral to the decision-making process. Healthcare providers must respect cultural diversity and provide care that aligns with the client&rsquo;s beliefs rather than dismissing them. Disregarding cultural or traditional values can violate the principle of cultural competence and sensitivity.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">b. The nurse respects that the hospital has the final authority to make decisions for the client:</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"> The hospital or healthcare provider does not have the authority to override a competent client&rsquo;s autonomous decision. This choice disregards the ethical principle of autonomy and falsely prioritizes institutional authority over client-centered care.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">d. The nurse defends the choice to continue cancer therapy because that is what is best for the client:</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"> While beneficence (acting in the client&rsquo;s best interest) is an ethical principle, it does not override autonomy. The client's definition of "best" may differ from the healthcare provider&rsquo;s perspective. Forcing treatment violates the client&rsquo;s right to refuse care and can lead to ethical and legal repercussions.</span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 42</h3>
                <p><b>The nurse wants to improve collaborative decision-making skills. Which action promotes collaboration between nurses and the Inter-professional ​team?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Delaying feedback on results to ensure that all collected data were reviewed by the team first</li><li>2. Removing the client from the ​decision-making process</li><li>3. Sharing responsibility of the outcome of the decision</li><li>4. Depending on physician leadership to ultimately make the decision for the team</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%;"><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Collaboration in healthcare is built on mutual respect, shared responsibilities, and teamwork among all members of the Inter-professional team, including nurses, physicians, and other healthcare professionals. Sharing responsibility for the outcomes of decisions fosters accountability, inclusivity, and trust within the team. It ensures that all team members contribute their expertise while promoting a patient-centered approach to care.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-outline-level: 3;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Analysis of Distractors:</span></strong></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">a. Delaying feedback on results to ensure that all collected data were reviewed by the team first:</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"> Delaying feedback can hinder timely decision-making and negatively impact patient outcomes. Effective collaboration requires open and prompt communication, allowing the team to act quickly and make informed decisions without unnecessary delays.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">b. Removing the client from the decision-making process:</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"> Excluding the client violates the principles of patient-centered care and autonomy. Clients are integral to decision-making as their preferences, values, and goals should guide the healthcare plan. Collaboration must include the client whenever possible.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">d. Depending on physician leadership to ultimately make the decision for the team:</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"> While physicians often provide valuable input, effective collaboration requires contributions from all team members, including nurses. Solely depending on one discipline undermines the inter-professional nature of the team and diminishes the value of nursing and other professional perspectives.</span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 43</h3>
                <p><b>A nurse is working as the designated leader of a group of healthcare providers in a community clinic setting. The team members are working to decrease the number of adolescent pregnancies in the community. They have defined the problem and are now focusing on objectives and considering various viewpoints presented by the group. The nurse is tasked with helping the team stay focused in order to address the defined problem. Which of the competencies of collaboration does this describe?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Decision making</li><li>2. Mutual respect</li><li>3. Trust</li><li>4. Communication</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The team is collaborating to decrease the number of adolescent pregnancies in the community. Respect and trust are required in a collaboration process. However, collaboration among team members requires shared responsibility for decision making. </li><li>The team must follow each step of the decision-making process at the objectives of the effort. Each team member has to respect and consider the viewpoints of other members. The leader acts by providing guidance and direction to the group. Hence, option a is correct.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 44</h3>
                <p><b>One of the demerits of functional nursing is:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Clients may feel impersonal</li><li>2. Time consuming</li><li>3. Difficult to organize</li><li>4. Ignores Aptitudes and desires of nurse</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>One of the demerits of functional nursing is that the clients may feel impersonal as there is less nurse patient interaction and many nurses are involved in taking care of a single patient. It becomes difficult for the patient to recognize the real nurse. Nurse-patient relationship is not developed fully.</li><li>Other options are incorrect, as functional nursing is not time consuming, rather it saves time as the work is divided. Also, functional nursing helps to organize the work properly and the best use of nurse’s aptitudes, experience & desires is through functional nursing.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 45</h3>
                <p><b>In team nursing, all are the responsibilities of a team leader EXCEPT:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Assigning team members to patients</li><li>2. Planning & conducting conference</li><li>3. Knowing the needs of the nurses</li><li>4. Changing duty according to workload</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>In team nursing, the team leader’s responsibilities typically include:</b> <ul ><li><b>Assigning team members to patients (a):</b> The team leader is responsible for making patient assignments based on the skills and competencies of team members.</li><li><b>Planning & conducting conferences (b):</b> The team leader organizes and leads team meetings or conferences to discuss patient care and the overall progress of the team.</li><li><b>Knowing the needs of the nurses (c):</b> The team leader is responsible for understanding the needs, strengths, and weaknesses of the nursing staff to ensure effective patient care. </li></ul><p>However, changing duty according to workload (d) is not typically the responsibility of the team leader in team nursing. This task usually falls under the nurse manager’s or administrator’s role, who oversees staffing and workload adjustments across the unit or department.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 46</h3>
                <p><b>Assignment of any authority from manager to subordinates to carry out specific activities is known as ___________:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Centralization</li><li>2. Staffing</li><li>3. Delegation</li><li>4. Coordination</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Assignment of any authority from manager to subordinates to carry out specific activities is known as delegation. It is basically the shifting of authority and responsibility for a specific purpose, tasks, or decisions from a superior (manager or leader) to sub-ordinate.</li><li><b>Centralization</b> in management means that the power to take decisions is concentrated in the hands of the leaders who are at the top level in the organizational hierarchy.</li><li><b>Staffing</b> is a recruitment process in which the knowledge & skills of the candidate are assessed before giving the specific job roles & responsibilities.</li><li><b>Co-ordination</b> in management is the functioning of different departments and groups in sync. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 47</h3>
                <p><b>The RN is caring for a 48-year-old patient with a pulmonary embolus. The patient complains of chest pain, shortness of breath and is put on O2. Which of the following interventions can be the RN delegate to the LPN?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Evaluating the patient’s complaint of chest pain</li><li>2. Monitoring lab values for changes in oxygen saturation</li><li>3. Assessing for symptoms of respiratory failure</li><li>4. Auscultating the lungs for crackles</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>LPNs (Licensed Practical Nurses) can perform specific tasks that involve data collection and basic nursing skills under the supervision of an RN (Registered Nurse). Auscultating lungs for crackles is a data-collection activity that falls within the scope of practice for an LPN. The LPN can report their findings to the RN, who interprets the data and plans the appropriate interventions.</li></ul><p><b>Analysis of Distractors:</b><ul ><li><b>Evaluating the patient’s complaint of chest pain:</b>Evaluation is a part of the nursing process, which is the RN’s responsibility. It involves critical thinking and decision-making to determine the severity and cause of the patient’s chest pain, which is outside the LPN’s scope of practice.</li><li><b>Monitoring lab values for changes in oxygen saturation :</b>While LPNs can monitor vital signs and report findings, interpreting lab values and identifying trends to make clinical decisions is within the RN’s scope. The RN must assess lab data to guide care for critical conditions like pulmonary embolism.</li><li><b>Assessing for symptoms of respiratory failure :</b>Assessment involves clinical judgment and critical thinking, which are responsibilities of the RN. While LPNs can observe and report symptoms, diagnosing or evaluating respiratory failure is beyond their scope of practice.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 48</h3>
                <p><b>Telemedicine is the use of medical information exchange from one site to another via:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Verbal communication</li><li>2. Print communication</li><li>3. Written communication</li><li>4. Electronic communication</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%;"><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Telemedicine involves the exchange of medical information between healthcare providers or between providers and patients through electronic means such as video conferencing, emails, telephonic consultations, and digital data transmission. It enables remote diagnosis, treatment, monitoring, and patient education, leveraging technology to improve healthcare accessibility and efficiency.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-outline-level: 3;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Analysis of Distractors:</span></strong></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">a. Verbal communication</span></strong></p><ul type="disc"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">While verbal communication may occur during telemedicine (e.g., through video or phone calls), it is not the defining method. Telemedicine relies on electronic platforms for the exchange of information, which distinguishes it from traditional in-person communication.</span></li></ul><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">b. Print communication</span></strong></p><ul type="disc"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l2 level1 lfo2; tab-stops: list 36.0pt;"><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Print communication, such as physical documents or reports, does not involve the electronic exchange of information, which is central to telemedicine.</span></li></ul><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">c. Written communication</span></strong></p><ul type="disc"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;"><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Written communication could involve handwritten notes or physical letters, which do not leverage electronic systems. Telemedicine specifically utilizes digital and electronic means to facilitate the exchange of information.</span></li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 49</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The communication in which managers interact with managers, physicians and groups of people in other departments in the organization who are NOT at the same level in the hierarchy as them is called:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vertical communication</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Horizontal communication</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Diagonal communication</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Upward communication</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Diagonal communication occurs when individuals or groups interact across different levels and departments within an organization, bypassing the traditional hierarchical structure. This type of communication is essential for fostering collaboration and efficiency, especially in complex organizations where departments and hierarchies are interdependent.</p>
<p><img title="image003.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/9624843f-2076-416c-b00d-c1fc359e9b8e.jpg" alt="" width="289" height="217" /></p>
<h3><strong>Analysis of Distractors:</strong></h3>
<ol>
<li><strong> Vertical communication</strong></li>
</ol>
<ul>
<li><strong>Rationale for elimination:</strong> Vertical communication flows between different levels of the hierarchy, either upward (from subordinates to superiors) or downward (from superiors to subordinates). It does not involve interaction across departments or with individuals at different hierarchical levels.</li>
</ul>
<ol>
<li><strong> Horizontal communication</strong></li>
</ol>
<ul>
<li><strong>Rationale for elimination:</strong> Horizontal communication occurs between individuals or groups at the same level within the organizational hierarchy, typically within the same department or function. It does not involve interaction with other hierarchical levels.</li>
</ul>
<ol>
<li><strong> Upward communication</strong></li>
</ol>
<ul>
<li><strong>Rationale for elimination:</strong> Upward communication refers to the flow of information from lower levels to higher levels in the hierarchy, such as from employees to managers. It does not encompass interaction across departments or between levels that are not directly connected hierarchically.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 50</h3>
                <p><b>A nurse manager requires several skills to be effective in her work. Which of the following skills is the most important skill to be an effective nurse manager at all levels of management?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Technical skill</li><li>2. Conceptual skill</li><li>3. Human skill</li><li>4. Supervisory skill</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p style="line-height: 115%;">Human skill is the ability to work effectively with people, communicate, motivate, and lead teams. For a nurse manager, human skills are essential at all levels of management because healthcare is inherently people-centred. Nurse managers must interact with diverse individuals, including patients, staff, physicians, and administrators, ensuring collaboration, conflict resolution, and team cohesion.</p><h3 style="line-height: 115%;"><strong><span style="font-size: 12.0pt; line-height: 115%;">Analysis of Distractors:</span></strong></h3><p style="line-height: 115%;"><strong>a. Technical skill</strong></p><ul type="disc"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%;">Rationale for elimination:</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif;"> While technical skills (e.g., clinical expertise) are important at lower levels of management, they become less critical at higher levels. A nurse manager primarily oversees operations, delegates tasks, and supports the team, relying on their staff's technical expertise rather than performing technical tasks themselves.</span></li></ul><p style="line-height: 115%;"><strong>b. Conceptual skill</strong></p><ul type="disc"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l1 level1 lfo2; tab-stops: list 36.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%;">Rationale for elimination:</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif;"> Conceptual skills (e.g., strategic thinking and planning) are crucial for higher-level managers who focus on organizational goals and policies. While important, they are not as universally applicable as human skills for nurse managers operating at all levels.</span></li></ul><p style="line-height: 115%;"><strong>d. Supervisory skill</strong></p><ul type="disc"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l2 level1 lfo3; tab-stops: list 36.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%;">Rationale for elimination:</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif;"> Supervisory skills are a subset of human skills and focus on guiding and monitoring team performance. However, human skills are broader, encompassing emotional intelligence, communication, and relationship-building, which are critical for effective management.</span></li></ul><p>&nbsp;</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 51</h3>
                <p><b>Which level of authority corresponds to administration in an organization?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Middle-level activity</li><li>2. Top-level activity</li><li>3. Operational-level activity</li><li>4. Supervisory-level activity</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul type="disc"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Administration</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"> is primarily concerned with <strong>setting the organization's objectives</strong> and formulating <strong>major policies</strong>. It is a <strong>strategic function</strong> that involves decision-making at the <strong>highest level</strong> of the organization, which is typically carried out by top management. These decisions focus on the <strong>long-term goals</strong> and the overall direction of the organization, including governance, budgetary control, and major policy setting. Therefore, <strong>administration</strong> is classified as a <strong>top-level activity</strong>.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Distractor A: Middle-level activity</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Management</strong>, in contrast to administration, is more focused on <strong>executing the policies</strong> and decisions made by the administration. Middle-level managers interpret the policies laid down by top management and ensure that they are <strong>implemented</strong> at <strong>operational levels</strong>. Therefore, this choice is incorrect as it applies to <strong>management</strong>, not <strong>administration</strong>.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Distractor C: Operational-level activity</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Operational-level activities</strong> are associated with <strong>day-to-day management tasks</strong>, such as handling routine operations and supervising the workforce. These activities are typically carried out by <strong>lower-level</strong> or <strong>supervisory managers</strong>, not by the <strong>administration</strong>. Thus, this distractor is not relevant to the nature of <strong>administrative authority</strong>.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Distractor D: Supervisory-level activity</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Supervisory-level activities</strong> involve overseeing the work of employees and ensuring that tasks are performed according to established guidelines. This is not aligned with <strong>administration</strong>, which has a broader, <strong>strategic focus</strong>. Therefore, this distractor is incorrect for the same reason as the other lower-level activity distractors.</span></li></ul><p>&nbsp;</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 52</h3>
                <p><b>Which of the following is NOT a component of the POSDCORB framework?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Planning</li><li>2. Organizing</li><li>3. Staffing</li><li>4. Evaluating</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul type="disc"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Evaluating</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"> is <strong>not</strong> a part of the <strong>POSDCORB</strong> framework. The framework focuses on the following <strong>seven functions</strong> of management: <strong>Planning, Organizing, Staffing, Directing, Coordinating, Reporting, and Budgeting</strong>. Evaluating, although an important managerial function, is <strong>not explicitly listed</strong> within this model.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Distractor A (Planning):</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Planning</strong> is an essential component of POSDCORB. It involves determining objectives and deciding on the actions to achieve those objectives. It is a core function of the management process.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Distractor B (Organizing):</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Organizing</strong> refers to arranging resources and tasks to achieve the objectives set in the planning process. It is one of the key functions in the POSDCORB framework.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l0 level1 lfo1; tab-stops: list 36.0pt;"><strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;">Distractor C (Staffing):</span></strong><span lang="EN-US" style="font-size: 12.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-IN;"><br><strong>Staffing</strong> includes recruiting, selecting, and training the right people for the organization. It is a significant part of the POSDCORB model, ensuring that the right personnel are in place to carry out the plans and organizational functions.</span></li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 53</h3>
                <p><b>A nursing manager assigns tasks to nurses based on their expertise, ensuring tasks are clearly defined for efficiency. Which principle is being applied?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Unity of Direction</li><li>2. Division of Work</li><li>3. Scalar Chain</li><li>4. Authority and Responsibility</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Division of Work</b> increases efficiency by specializing tasks based on expertise. In this scenario, the nursing manager ensures that each nurse is assigned tasks that match their skills, optimizing performance and ensuring tasks are completed efficiently.</li><li><b>Unity of Direction (A)</b> involves guiding the team towards shared goals, not assigning tasks based on skills.</li><li><b>Scalar Chain (C)</b> pertains to the chain of command or hierarchy of authority, and does not relate to task division.</li><li><b>Authority and Responsibility (D)</b> focuses on the balance between decision-making power and duties, which is not directly concerned with how tasks are delegated or specialized.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 54</h3>
                <p><b>A nurse leader encourages the team to prioritize patient care goals over personal preferences, ensuring that the team’s collective effort aligns with the hospital’s mission. Which principle is being applied?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Subordination of Individual Interest to General Interest</li><li>2. Unity of Command</li><li>3. Discipline</li><li>4. Authority and Responsibility</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><b>Scientific</b> <ul ><li><b>Subordination of Individual Interest to General Interest</b> emphasizes the need for individuals to align personal interests with the goals of the organization. The leader is ensuring the team’s priorities match the larger organizational mission.</li><li><b>Unity of Command (B)</b> relates to receiving orders from one superior, which isn’t the focus here.</li><li><b>Discipline (C)</b> involves following rules, but the scenario is more about prioritizing organizational goals over personal preferences.</li><li><b>Authority and Responsibility (D)</b> deals with the balance between decision-making power and duties, but does not directly address alignment of interests.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 55</h3>
                <p><b>A nurse manager sets up a clear communication hierarchy for shift changes and patient care. Which principle is applied?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Equity</li><li>2. Unity of Command</li><li>3. Discipline</li><li>4. Scalar Chain</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Scalar Chain</b> ensures a clear communication flow through a structured hierarchy, which the nurse manager establishes for shift changes and patient care. This principle emphasizes the line of authority and the orderly flow of information within the organization.</li><li><b>Unity of Command (B)</b> refers to the principle that an employee should receive instructions from only one superior at a time, which is not directly related to establishing communication hierarchies.</li><li><b>Equity (A) and Discipline (C)</b> focus on fairness and adherence to rules and standards, but they do not address the communication structure or organizational hierarchy for managing workflow.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 56</h3>
                <p><b>In VED analysis, which category includes items whose absence would halt critical operations or services?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Vital (V)</li><li>2. Essential (E)</li><li>3. Desirable (D)</li><li>4. Critical (C)</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>In VED analysis, inventory items are classified based on their importance:<ul><li><strong>Vital (V):</strong> Items that are critical to operations and must be available at all times. Their absence would lead to halted production, disrupted services, or compromised patient care (e.g., oxygen tanks in healthcare).</li><li><strong>Essential (E):</strong> Items that are important but not immediately critical. Their absence may cause inconveniences but operations can continue temporarily (e.g., surgical gloves or spare parts).</li><li><strong>Desirable (D):</strong> Items that improve efficiency or experience but are non-essential. Their absence does not affect critical operations (e.g., coffee machines or promotional items).</li></ul></li><li><strong>Option C (Desirable)</strong> refers to items that enhance efficiency or aesthetics but are non-essential.</li><li><strong>Option B (Essential)</strong> is important but not critical.</li><li><strong>Option D (Critical)</strong> is not a standard term used in VED analysis.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 57</h3>
                <p><b>Which of the following best describes bureaucratic leadership in nursing management?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Empowering staff to make independent decisions.</li><li>2. Relying on rules, procedures, and hierarchies for decision-making.</li><li>3. Emphasizing flexibility in decision-making.</li><li>4. Encouraging collaboration and shared decision-making.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><b>Scientific</b> <ul ><li><b>Option B</b> is correct because bureaucratic leadership is characterized by a reliance on established rules, procedures, and formal hierarchies to guide decision-making. This approach is common in environments where consistency, safety, and compliance are critical, such as healthcare settings. The strict adherence to rules ensures predictable outcomes and minimizes errors, which is essential in managing complex healthcare operations.</li></ul><p><b>Distractors:</b><ul ><li><b>Option A:</b> Incorrect. Empowering staff to make independent decisions describes a more democratic or transformational leadership style, where autonomy is encouraged.</li><li><b>Option C:</b> Incorrect. Bureaucratic leadership is focused on following structured processes, not on flexibility. It prioritizes consistency over adaptability.</li><li><b>Option D:</b> Incorrect. Encouraging collaboration and shared decision-making is more aligned with democratic or transformational leadership styles, where leadership is less hierarchical and more participative.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 58</h3>
                <p><b>In the context of group dynamics, what happens during the “adjourning” stage?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. The group focuses on organizing and defining roles.</li><li>2. The group disbands after achieving its objectives, reflecting on successes and areas for improvement.</li><li>3. The group members experience conflict as they work toward their objectives.</li><li>4. The group begins brainstorming ideas for the next project.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li><strong>Option B</strong> is correct because the &ldquo;adjourning&rdquo; stage is the final phase in Tuckman&rsquo;s model of group development (forming, storming, norming, performing, adjourning). During this phase, the group has achieved its goals, and members often reflect on their progress, celebrate successes, and analyze what could have been done differently to improve the process. This reflection helps consolidate learning and provides closure to the group&rsquo;s work.</li></ul><p><strong>Distractors:</strong></p><ul><li><strong>Option A:</strong> Incorrect. Organizing and defining roles happens during the &ldquo;forming&rdquo; stage, where the group members establish roles and procedures.</li><li><strong>Option C:</strong> Incorrect. Conflict typically arises in the &ldquo;storming&rdquo; phase, where members may have differing ideas or approaches.</li><li><strong>Option D:</strong> Incorrect. Brainstorming for the next project is usually part of the &ldquo;forming&rdquo; stage of a new group or project, not during adjourning.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 59</h3>
                <p><b>A nurse manager is planning a strategy to influence policy changes in the healthcare system. Which of the following is an example of direct lobbying?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Organizing a community petition to advocate for improved patient care standards</li><li>2. Writing a letter to a legislator to request support for a healthcare bill</li><li>3. Encouraging patients to contact their representatives about healthcare reform</li><li>4. Hosting a public forum to educate the community about health policy changes</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Direct lobbying involves communicating directly with policymakers, such as legislators, to influence their decisions. Writing a letter to a legislator is an example of direct lobbying because it directly engages with the policymaker to request support or opposition to a specific bill or policy. This type of lobbying is typically focused on influencing legislative action through one-on-one communication.</li></ul><p><b>Distractors:</b><ul ><li><b>Organizing a community petition to advocate for improved patient care standards:</b> This represents grassroots lobbying, where the focus is on mobilizing the public to take collective action. This is indirect, as it seeks to influence lawmakers through public pressure rather than direct communication.</li><li><b>Encouraging patients to contact their representatives about healthcare reform:</b> This is also grassroots lobbying, which involves mobilizing constituents to contact their lawmakers to express their views. It is indirect lobbying because the message is conveyed by the public, not by direct communication from the advocate.</li><li><b>Hosting a public forum to educate the community about health policy changes:</b> This is an example of grassroots lobbying aimed at raising awareness. Although it provides education, it does not directly influence policymakers. It is aimed at building public support, which may indirectly impact policy change.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 60</h3>
                <p><b>Which decision-making tool involves structured communication among experts, using an iterative process to reach a consensus?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Brainstorming</li><li>2. Delphi Technique</li><li>3. SWOT Analysis</li><li>4. Fishbone Diagram</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p style="line-height: 115%;"><strong><span style="font-size: 14.0pt; line-height: 115%; mso-fareast-font-family: Calibri;">Delphi Technique (Correct Answer):</span></strong></p><ul type="disc"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l2 level1 lfo1; tab-stops: list 36.0pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">The <strong>Delphi Technique</strong> is a <strong>structured communication process</strong> designed to achieve consensus among a group of experts.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l2 level1 lfo1; tab-stops: list 36.0pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">It is particularly effective in <strong>complex decision-making scenarios</strong> where diverse opinions are expected, and direct group interaction might lead to bias or domination by certain individuals.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l2 level1 lfo1; tab-stops: list 36.0pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">The process includes <strong>multiple rounds of anonymous feedback</strong>, allowing experts to refine their answers based on the group&rsquo;s collective insights.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l2 level1 lfo1; tab-stops: list 36.0pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">This technique is extensively used in <strong>forecasting future trends, problem-solving, and policy-making in healthcare</strong>, ensuring decisions are <strong>evidence-based and unbiased</strong>.</span></li></ul><p style="line-height: 115%;"><strong><span style="font-size: 14.0pt; line-height: 115%; mso-fareast-font-family: Calibri;">Why Other Options Are Incorrect:</span></strong></p><p style="margin-left: 36.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l1 level1 lfo2; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 14.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="font-size: 14.0pt; line-height: 115%; mso-fareast-font-family: Calibri;">Option A: Brainstorming</span></strong></p><ul type="disc"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l1 level2 lfo2; tab-stops: list 72.0pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Involves <strong>idea generation in group settings</strong>, often in a free-flowing manner.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l1 level2 lfo2; tab-stops: list 72.0pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">While it encourages creativity, it lacks the structured and iterative nature of the Delphi Technique. It is also prone to <strong>groupthink</strong> or <strong>dominance by outspoken participants</strong>, making it less suitable for consensus-building.</span></li></ul></ul><p style="margin-left: 36.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l1 level1 lfo2; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 14.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="font-size: 14.0pt; line-height: 115%; mso-fareast-font-family: Calibri;">Option C: SWOT Analysis</span></strong></p><ul type="disc"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l1 level2 lfo2; tab-stops: list 72.0pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Focuses on evaluating <strong>Strengths, Weaknesses, Opportunities, and Threats</strong> in a specific situation or organization.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l1 level2 lfo2; tab-stops: list 72.0pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">It is a strategic planning tool but does not involve the <strong>iterative feedback</strong> or expert consensus characteristic of the Delphi Technique.</span></li></ul></ul><p style="margin-left: 36.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l1 level1 lfo2; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span style="font-size: 10.0pt; mso-bidi-font-size: 14.0pt; line-height: 115%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;"><span style="mso-list: Ignore;">&middot;<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span style="font-size: 14.0pt; line-height: 115%; mso-fareast-font-family: Calibri;">Option D: Fishbone Diagram (Ishikawa Diagram)</span></strong></p><ul type="disc"><ul type="circle"><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l1 level2 lfo2; tab-stops: list 72.0pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">A root-cause analysis tool used to identify potential causes of a problem.</span></li><li class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; line-height: 115%; mso-list: l1 level2 lfo2; tab-stops: list 72.0pt;"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">While it aids in problem-solving, it does not involve <strong>expert consensus</strong> or structured communication over iterative rounds.</span></li></ul></ul><h3 style="line-height: 115%;"><span style="font-size: 14.0pt; line-height: 115%;">Key Points to Remember:</span></h3><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 36.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l0 level1 lfo3; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman';"><span style="mso-list: Ignore;">1.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%;">Delphi Technique:</span></strong></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 72.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l0 level2 lfo3; tab-stops: list 72.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 10.0pt; mso-bidi-font-size: 14.0pt; line-height: 115%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New';"><span style="mso-list: Ignore;">o<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%;">Structured and iterative process</span></strong><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 72.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l0 level2 lfo3; tab-stops: list 72.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 10.0pt; mso-bidi-font-size: 14.0pt; line-height: 115%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New';"><span style="mso-list: Ignore;">o<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Experts provide <strong>anonymous input</strong> to avoid bias.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 72.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l0 level2 lfo3; tab-stops: list 72.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 10.0pt; mso-bidi-font-size: 14.0pt; line-height: 115%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New';"><span style="mso-list: Ignore;">o<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Promotes <strong>evidence-based, consensus-driven decisions</strong> in complex healthcare scenarios.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 36.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l0 level1 lfo3; tab-stops: list 36.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman';"><span style="mso-list: Ignore;">2.<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><strong><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%;">Why Delphi is superior:</span></strong></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 72.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l0 level2 lfo3; tab-stops: list 72.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 10.0pt; mso-bidi-font-size: 14.0pt; line-height: 115%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New';"><span style="mso-list: Ignore;">o<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Eliminates groupthink.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 72.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l0 level2 lfo3; tab-stops: list 72.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 10.0pt; mso-bidi-font-size: 14.0pt; line-height: 115%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New';"><span style="mso-list: Ignore;">o<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Encourages diverse perspectives.</span></p><p class="MsoNormal" style="mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; margin-left: 72.0pt; text-indent: -18.0pt; line-height: 115%; mso-list: l0 level2 lfo3; tab-stops: list 72.0pt;"><!-- [if !supportLists]--><span lang="EN-US" style="font-size: 10.0pt; mso-bidi-font-size: 14.0pt; line-height: 115%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New';"><span style="mso-list: Ignore;">o<span style="font: 7.0pt 'Times New Roman';">&nbsp;&nbsp;&nbsp; </span></span></span><!--[endif]--><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif;">Ensures <strong>objective and reliable outcomes</strong> through iterative refinement.</span></p><p style="line-height: 115%;"><span style="font-size: 14.0pt; line-height: 115%;">This method is widely used in </span><strong><span style="font-size: 14.0pt; line-height: 115%; mso-fareast-font-family: Calibri;">healthcare planning, policy-making, and nursing management</span></strong><span style="font-size: 14.0pt; line-height: 115%;">, where decisions require the collaboration of multiple experts without direct interaction.</span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 61</h3>
                <p><b>Identify the type of fever in which the daily variation in temperature is not more than 2°C in 24 hours and remains above normal throughout the day.</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Intermittent fever</li><li>2. Remittent fever</li><li>3. Continuous fever</li><li>4. Inverse fever</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li> <b> Continuous fever:</b> Constant or continuous fever is one in which the temperature varies not more than 2 degrees between morning and evening and does not reach normal for days or week.</li><li>Remittent fever:</b> It is characterized by variations of more than 2 degree between morning and evening but does not reach normal. </li><li><b>Intermittent fever:</b> It is also known as quotidian fever. The temperature rises from normal or subnormal to high fever and back to normal at regular intervals. The interval may vary from a few hours to 3 days. This type of fever usually occurs during the course of an infectious disease.</li><li><b>Inverse fever:</b> In this type the highest range of temperature is recorded in the morning hours and lowest in the evening. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 62</h3>
                <p><b>The sudden return to a normal temperature from very high fever is called as:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Lysis</li><li>2. Crisis</li><li>3. Thermostasis</li><li>4. Homeostasis</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The sudden return to a normal temperature from very high fever is called as crisis. Option b is the correct answer.</li><li><b>Option A:</b> The fall of temperature in zigzag manner to normal is known as Lysis.</li><li><b>Option C:</b> Thermostasis is the maintenance of a stable body temperature in human beings. </li><li><b>Option D:</b> Hemostasis is the arrest of bleeding, whether it be by normal vasoconstriction (the vessel walls closing temporarily), by an abnormal obstruction (such as a plaque) or by coagulation or surgical means (such as ligation).</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 63</h3>
                <p><p><strong>Identify the image given below:</strong></p><p><strong><img title="image003.jpg" src="data:image/jpeg;base64,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" alt="" width="300" height="196"></strong></p></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Electronic thermometer</li><li>2. Single use thermometer</li><li>3. Temporal artery thermometer</li><li>4. Glucometer</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p>Single use thermometer</p><table style="border-collapse: collapse; width: 99.9979%;" border="1"><colgroup><col style="width: 49.9825%;"><col style="width: 49.9825%;"></colgroup><tbody><tr><td style="width: 233.75pt; border: solid windowtext 1.0pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" width="312"><p class="MsoListParagraph" style="text-align: center; background: white; mso-background-themecolor: background1;" align="center"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-themecolor: text1;">Electronic thermometer</span></p><p class="MsoNormal" style="margin-bottom: .0001pt; text-align: center; line-height: normal; background: white; mso-background-themecolor: background1;" align="center"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-themecolor: text1; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">&nbsp;</span></p></td><td style="width: 233.75pt; border: solid windowtext 1.0pt; border-left: none; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="312"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal; background: white; mso-background-themecolor: background1;"><span style="font-size: 14.0pt; mso-bidi-font-size: 11.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-themecolor: text1; mso-font-kerning: 0pt; mso-ligatures: none; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA; mso-no-proof: yes;"><img title="image004.jpg" src="data:image/jpeg;base64,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" alt="" width="420" height="250"><br><!--[endif]--></span></p></td></tr><tr><td style="width: 233.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" width="312"><p class="MsoListParagraph" style="text-align: center; background: white; mso-background-themecolor: background1;" align="center"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-themecolor: text1;">Temporal artery thermometer</span></p><p class="MsoNormal" style="margin-bottom: .0001pt; text-align: center; line-height: normal; background: white; mso-background-themecolor: background1;" align="center"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-themecolor: text1; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">&nbsp;</span></p></td><td style="width: 233.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="312"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal; background: white; mso-background-themecolor: background1;"><span style="font-size: 14.0pt; mso-bidi-font-size: 11.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-themecolor: text1; mso-font-kerning: 0pt; mso-ligatures: none; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA; mso-no-proof: yes;"><img title="image005.jpg" src="data:image/jpeg;base64,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" alt="" width="250" height="237"><br><!--[endif]--></span></p></td></tr><tr><td style="width: 233.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" width="312"><p class="MsoListParagraph" style="text-align: center; background: white; mso-background-themecolor: background1;" align="center"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-themecolor: text1;">Single use thermometer</span></p><p class="MsoNormal" style="margin-bottom: .0001pt; text-align: center; line-height: normal; background: white; mso-background-themecolor: background1;" align="center"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-themecolor: text1; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">&nbsp;</span></p></td><td style="width: 233.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="312"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal; background: white; mso-background-themecolor: background1;"><span style="font-size: 14.0pt; mso-bidi-font-size: 11.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-themecolor: text1; mso-font-kerning: 0pt; mso-ligatures: none; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA; mso-no-proof: yes;"><img title="image003.jpg" src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/2wBDAAoHBwkHBgoJCAkLCwoMDxkQDw4ODx4WFxIZJCAmJSMgIyIoLTkwKCo2KyIjMkQyNjs9QEBAJjBGS0U+Sjk/QD3/2wBDAQsLCw8NDx0QEB09KSMpPT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT09PT3/wAARCACTAOEDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDvM0lBpKozCjNJSUCFozSUlADqTNJSZoAfmkpMmk3UALmjNNzRQA7NFNzQKAHZozTc0ZoAdRmm0ZoAdmlzTcijNADhS5ptGaAHUtNpc0AKKWm0tAC0uaQUuaBhRRmigBppKDSZoELSUlITQAuaM00mjNACk0ZptGaAFJoptGaAFozSUZoAWikozQAtFJRQA6im5ooAdS5plLmgBwNGabS0AOBpc02loAdQKbmlzQAuaUGkopAOopM0UANpM0ZpDTADSUUlAC0maKSgBaSikNAC0lFFABRRmjNABRRRQAUUUlAC0UZozQAtFJRmgB1FJmgGgB1Lmm0UAOpc03NLQA7NLTaUUALRSUUANopKSgAJpCatLpl3IgZUAB6ZYCj+xrz0T/voUrhZlTNJuq5/Y156J/31TTpF4P4Afo1FwsyruozUzaber/ywY/TFMNldjrbyf980wGZozQYJ16wyD/gJppWQdY3H/ATQA7NGaZ8391vyoyf7p/KgB2aXNMyfQ/lS/N/db8qAHZpM0m2Q9I3P0U0ohnPSCQ/8ANABmjNPWyu26W0n4ipBpl83/LAj6sKAIc0bhVpdGvT1EY+rUybTXtyBNPEhPY5/wpXCzINwo3Cp/wCzWCBjcR4Zdw4PT8qcNMP/AD8x9cfdP+FF0PlZXDUbverq6M5UH7TEAenBz+VQ/YHGeXPX+D0ouFmQ5FLmrCaa7uFy4y2MlenGc0txpk9qpZsOv95e1FwsyDNLSYNKKYhaKKKAGE0AZGPWkNApAberG+GluNMGboAbeV49fvcVxIT4nFZh5mmjfxGzbMp3B9CT0rfkvbiOHEcrjHTBrmtQ1PWg58m7uQPZ6LFcx6LF5vkx+b/rNo3Y9cc0/Dn1/KvJjqviL/n8u/8Av4aiku9dl/1l1dt9ZWosLmPXMEdePrSeai/edB9Wrx77Pqcv3jKf95yaeml359PzosHMeuPe26/euYV+sg/xqpc6pZiJx/aNvGxBwfNUEGvNl0S8frIB9BT/APhGpZPvy/pRYOY6OLXNRt7aNG1fSJHAG95JQSTt56f7X6UxPFGpO7qb/RVCMoyz8MMAkj8cisJPCaD7ztUq+FIO7N+dAuY2pNVvZ5HaPxBpcTHB/dnK4wcgA8gk7Tn2NXIb3OoK82vQfZSJQY1m5XO3ZzjnGG/MVzy+F7df7351IPDVv/tfnRYOY7O31TT4VYHV45dxyDJKOPYVOusWDfd1C2P/AG2WuEPhm29W/OmN4Wt+xb86LD5j0IX1q/3bqA/SRf8AGniRG+7Ih+jCvNm8Kxdmaoz4YK/claiwcx6fjPrWTrMUhlhZA2Q452k1w40S9j/1V5KPo5pWstZUYXUbgj/rq3+NFg5jtEjmls4CyPkwHPynOePapBbSeYf3Ugy/90/3fpXB/Ztc/wCf+4/7+t/jS/ZtaPW9n/7+t/jS5SlUOxvLWYz2ri2kk2xoD8p4IYe1XXs5CX/dsQS/RfX8K4A2Wrnrdzf9/W/xoFlqv/PzN/38ajlEp2PQ4bZ0mUmNgNwOSO23FM1TVbPTLaZTMHlkBxHv3Y4x+ArghY6ifvSO31Y01tLvG7j8qFGwOdzdg1RJWwCM1oLIGAI71zun6VJA26Rsk1vRJtWqIuTZopMUUAJikxTqbzQMTtio2hVuoqWkoAg+zR/3R+VL9mT+7UxpKAIfIT+6Kd5S9hUlJQITYvpRgelLRQMSjApaKAEopaKAExRilooATFFLiigBMUuBS4ooEN2j0pdopaKBhtFG0elKKWgBoRfSl2L6UuKUCgA2ClAxRS0AFFLRQA00lOpMUAJikp1IaAGmilxSUAJRS0UAJSUtGKAEopaKAEopaMUAJRS0YoASloxRQAUtFFABRRS0AAFLigUtABilopaAEpRRilxQAlFLRQAlFOpKAG0mKdSUAJikxTqSgBu2gin0lADaKXFJigBKKWigBKKWigBAKKXFFACUtLgUtADaWlooATFAFOooATFLijFKKACilooAKUUUtIYlFLRTASkp1FKwDMUU6imIbiilooASkp2KSgBMUmKdiigBuKMU6jFADMUc06igBvNLilxS0ANxRTqKAEoxS0tACAUuKKKAEpaWigBKWlpcUDEApcUDFLQAmKKdRQA2iiigBKKKKAEooooAKMUUUAJSmiigQ2loooASiiigBaSiigBaKKKACiiigBaKKKBhSiiigBaWiigApaKKACiiigD/2Q==" alt="" width="250" height="163"><br><!--[endif]--></span></p></td></tr><tr><td style="width: 233.75pt; border: solid windowtext 1.0pt; border-top: none; mso-border-top-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" width="312"><p class="MsoListParagraph" style="text-align: center; background: white; mso-background-themecolor: background1;" align="center"><span lang="EN-US" style="font-size: 14.0pt; line-height: 115%; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-themecolor: text1;">Glucometer</span></p><p class="MsoNormal" style="margin-bottom: .0001pt; text-align: center; line-height: normal; background: white; mso-background-themecolor: background1;" align="center"><span lang="EN-US" style="font-size: 14.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-themecolor: text1; mso-font-kerning: 0pt; mso-ligatures: none; mso-bidi-language: AR-SA;">&nbsp;</span></p></td><td style="width: 233.75pt; border-top: none; border-left: none; border-bottom: solid windowtext 1.0pt; border-right: solid windowtext 1.0pt; mso-border-top-alt: solid windowtext .5pt; mso-border-left-alt: solid windowtext .5pt; mso-border-alt: solid windowtext .5pt; padding: 0cm 5.4pt 0cm 5.4pt;" valign="top" width="312"><p class="MsoNormal" style="margin-bottom: .0001pt; line-height: normal; background: white; mso-background-themecolor: background1;"><span style="font-size: 14.0pt; mso-bidi-font-size: 11.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: Calibri; color: black; mso-themecolor: text1; mso-font-kerning: 0pt; mso-ligatures: none; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA; mso-no-proof: yes;"><img title="image006.jpg" src="data:image/jpeg;base64,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" alt="" width="250" height="175"><br><!--[endif]--></span></p></td></tr></tbody></table></li></ul></div></div>
            <div class="question">
                <h3>Question No: 64</h3>
                <p><b>The primary purpose of a patient’s medical record is to:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Provide validation for hospital charges.</li><li>2. Satisfy requirements of accreditation agencies.</li><li>3. Provide the nurse with a defense against malpractice.</li><li>4. Communicate accurate and timely information about the patient.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Patient’s medical record serves a purpose to communicate the health-related information of patient to healthcare provider directly involved in patient care. It also safeguards the nurse as patient’s medical record acts as a legal record. </li><li>Other options are distractors. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 65</h3>
                <p><b>A nurse has taught the patient how to use crutches. The patient went up and down the stairs using crutches with no difficulties. Which information will the nurse use for the “I” in PIE charting?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Patient went up and down stairs</li><li>2. Deficient knowledge regarding crutches</li><li>3. Demonstrated use of crutches</li><li>4. Used crutches with no difficulties</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>The PIE format of charting includes<ul><li>P&mdash;Problem,</li><li>I&mdash;Intervention, and</li><li>E&mdash;Evaluation</li></ul></li><li><strong>Option C:</strong> The intervention is &ldquo;Demonstrated use of crutches.&rdquo;</li><li>Options a and d: &ldquo;Patient went up and down stairs&rdquo; and &ldquo;Used crutches with no difficulties&rdquo; are examples of the Evaluation</li><li><strong>Option B:</strong> &ldquo;Deficient knowledge regarding crutches&rdquo; is the Problem</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 66</h3>
                <p><b>A boy is to be given dextrose 5% via an infusion pump. If the pump is set at 60 mL/h, how much dextrose will he receive in 2.5 hours?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 75 mL</li><li>2. 150 mL</li><li>3. 175 mL</li><li>4. 125 mL</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>According to the scenario, the given values are:</li><li>Total volume = ? (Needs to find out)</li><li>Total time = 2.5 hours</li><li>Flow rate = 60mL/hour</li><li>Here, we will use the flow rate mL/hour formula:</li></ul><p><img title="Screenshot 2025-01-03 162137.png" src="data:image/png;base64,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" alt="" width="380" height="248"></p><ul><li>Other options are distracters.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 67</h3>
                <p><b>An injection of morphine 8 mg is ordered. An ampoule is available containing 10mg/mL. What volume of drug should be drawn up by the nurse to administer the injection?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 0.5 mL</li><li>2. 0.8 mL</li><li>3. 1 mL</li><li>4. 2mL</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>According to the given scenario:<ul><li>The doctor&rsquo;s order = 8 mg</li><li>Stock strength = 10 mg per 1 mL volume of stock strength injection</li></ul></li></ul><p><img title="Screenshot 2025-01-03 162236.png" src="data:image/png;base64,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" alt="" width="413" height="117"></p><ul><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 68</h3>
                <p><b>Identify which of the following is Hartmann solution?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 0.9% Normal Saline</li><li>2. Ringer Lactate</li><li>3. Dextrose 5%</li><li>4. 0.45% Normal saline</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Lactated Ringer’s Solution</b> (also known as <b>Ringer’s Lactate or Hartmann solution</b>) is a crystalloid isotonic IV fluid designed to be the near-physiological solution of balanced electrolytes.</li><li>Sydney Ringer was the first to invent the Ringer’s saline solution in the year of 1880’s during his study of the beating of an isolated frog heart outside of the body. The use of Ringer’s original solution of inorganic salts slowly became more popular.</li><li>In the 1930’s, the original solution was further modified by American Pediatrician Alexis Hartmann for the purpose of treating acidosis. Hartmann added lactate, which mitigates changes in pH by acting as a buffer for acid. Thus the solution became known as «Ringer›s Lactate Solution» or «Hartmann›s Solution”</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 69</h3>
                <p><b>A patient who is hospitalized has just been diagnosed with diabetes. He is going to learn how to give himself injections. Which teaching method does the nurse use?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Simulation</li><li>2. Demonstration</li><li>3. Group instruction</li><li>4. One-on-one discussion</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>A nurse’s approach to teaching is different from teaching methods. Some situations require an educator to be directive. </li><li>Choose instructional methods that match a patient’s learning needs, the time available for teaching, the setting, the resources available, and your comfort level with teaching. </li><li><b>One-to-one discussion:</b> When teaching a patient at the bedside, in a healthcare provider’s office, or in the home, the nurse shares information directly. </li><li><b>Group instruction:</b> You may choose to teach patients in groups because of the advantages associated with group teaching. Groups are an economical way to teach a number of patients at one time, and patients are able to interact with one another and learn from the experiences of others. </li><li><b>Simulation:</b> It is a useful technique for teaching problem solving, application, and independent thinking. </li><li><b>Demonstration:</b> Demonstrations are most effective when learners first observe the educator and during a return demonstration have the chance to practice the skill. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 70</h3>
                <p><b>A single rescuer provides high-quality CPR to an adult male. He is unconscious, has no pulse, and is not breathing. What is the correct ratio of compressions and ventilations?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Fifteen chest compressions to one breath</li><li>2. Fifteen chest compressions to two breaths</li><li>3. Thirty chest compressions to two breaths</li><li>4. Thirty chest compressions to one breath</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The ratio of chest compressions to ventilations (one or two rescuers) in adult is 30 compressions to 2 ventilations. </li><li>Give 30 Compressions:</b></li><ul type ="circle"> <li>Make sure the person is lying on his back on a firm flat surface.</li><li>Move clothes out of the way. If a person’s clothes are difficult to remove, you can still provide compressions over clothing.</li><li>Put the heel of one hand on the lower half of the breastbone. Put the heel of your other hand on top of the first hand.</li><li>Compress at least 2 inches at a rate of 100 to 120 compressions per minute.</li><li>Do not compress deeper than 2.4 inches in adults as it may cause injuries</li><li>After each compression, allow complete chest recoil.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 71</h3>
                <p><b>Three things every first-aid kit must have are:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. A safety pin, cotton swabs and petroleum jelly</li><li>2. Plastic bags, iodine and vitamin B</li><li>3. Tweezers, hydrocortisone cream and painkillers</li><li>4. All of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>A good first aid kit will contain the basic things to attend to all sorts of minor injuries and illnesses. The first aid kit should include at least the following items:<ul><li>Bandages</li><li>Gauze pads</li><li>Hand sanitizer</li><li>Rubber/latex gloves</li><li>Wound cleaning wipes</li><li>Topical antibiotics</li><li>Over-the-counter pain relievers</li><li>Tweezers</li><li>Aspirin</li><li>Allergy pills such as diphenhydramine</li><li>Medical tape</li></ul></li><li>Other items can be included depending on your personal needs and comfort level of using them such as tourniquets, topical skin glue, eye drops, and/or an epinephrine pen (for allergies).</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 72</h3>
                <p><b>A first aider is present at the site of swallowed poisoning. The victim swallowed acid. Which of the following actions is appropriate to perform?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Induce vomiting</li><li>2. Assess airway patency, breathing and circulation</li><li>3. Find out the ingested substance</li><li>4. Place the patient in a supine position</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>In case of swallowed poisoning, assess airway patency, breathing and circulation, and position the victim in a side-lying position. </li><li>Vomiting is never induced in case of caustic ingestion.</li><li>Do not waste time in finding the poison, if not easily available.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 73</h3>
                <p><b>A nurse is applying a bandage to the patient’s forearm. In which way the nurse should apply the bandage?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Distal to proximal</li><li>2. Median to lateral</li><li>3. Proximal to distal</li><li>4. Lateral to median</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The Ans = is distal to proximal. Always wrap from the distal end to the proximal following the direction of venous circulation to promote the venous return. </li><li>Other options are distractors. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 74</h3>
                <p><b>A male client is admitted to the hospital with blunt chest trauma after a motor vehicle accident. The first nursing priority for this client would be to:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Assess the client’s airway</li><li>2. Provide pain relief</li><li>3. Encourage deep breathing and coughing</li><li>4. Splint the chest wall with a pillow</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>The first priority is to evaluate airway patency. Pain management and splinting are important for client comfort, but come after an airway assessment. Coughing and deep breathing may be contraindicated if the client has internal bleeding and other injuries.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 75</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Patient with small blisters filled with serous fluid is placed under which degree of burn?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1st Degree (superficial)</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>2nd Degree (partial-thickness)</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>3rd Degree (full-thickness)</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>4th Degree (deep full-thickness)</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Table:</strong> Degrees of Burns</p>
<p><img title="image018.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/80088784-0a85-40b7-9d3c-f2d2c2f0a004.jpg" alt="" width="407" height="247" /></p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 76</h3>
                <p><b>A patient with deep partial-thickness burns would present with which of the following symptoms?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Redness with no blister formation</li><li>2. Exposed muscles, nerves, blackened skin, extremely painful</li><li>3. Oozing at the burnt site</li><li>4. Charred tissue</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>In partial-thickness burns, the skin color is red and blisters may or may not be present. </li><li>Second-degree burns involve dermis also and blisters are present. </li><li>Third-degree burns involve muscles, nerves and soft tissues.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 77</h3>
                <p><b>Discharge from the hospital involves all of the following, except:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Patient leaves the hospital</li><li>2. Patient transferred to another facility</li><li>3. Instructions patient will need to fully recover</li><li>4. Observation, Investigation</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Discharge from the hospital is the point at which the patient leaves the hospital and either returns home or is transferred to another facility such as one for rehabilitation or to a nursing home. </li><li>Discharge involves the medical instructions that the patient will need to fully recover. It could be when attending doctor advice to leave the health care facility or patient himself wishes to leave.</li><li>Types of discharge:</b></li><ul type ="circle"> <li>Planned discharge</li><li>LAMA</li><li>Referrals and transfer</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 78</h3>
                <p><b>Which of the following helps in the proper discharge planning?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. To make a referral</li><li>2. To provide caregiver the with information about the client</li><li>3. To decrease the risk with limited resources</li><li>4. All of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Discharge planning begins the moment a patient is admitted to a healthcare facility. Discharge planning is a centralized, coordinated, interdisciplinary process that ensures that the patient has a plan for continuing care after leaving a healthcare agency. </li><li>Effective discharge planning often requires referrals to various healthcare disciplines. </li><li>Some tips on making the referral process successful:</b></li><ul type ="circle"> <li>Make a referral as soon as possible</li><li>Give the care provider receiving the referral as much information about the patient as possible. This avoids duplication of effort and exclusion of important information.</li><li>Involve the patient and family in the referral process, including selecting the necessary referral. Explain the service that the referral will provide, the reason for the referral, and what to expect from the services of the referral.</li><li>Determine what the referral discipline recommends for the patient’s care and include this in the treatment plan as soon as possible. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 79</h3>
                <p><b>A patient who decides to leave the hospital against medical advice (LAMA) must sign a form to:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Release the physician and hospital from legal responsibility for the patient’s health status</li><li>2. Ethically illustrate that the patient has control of his or her own care and treatment</li><li>3. Use in the event of readmission</li><li>4. Indicate the patient’s wishes</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The importance of making the patient sign the form is to protect the health professionals from legal implications.</li><li>All other options are incorrect as they are not worth considering. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 80</h3>
                <p><b>While receiving the shift duty report at the patient bedside, you noticed that the patient I.V. infusion has infiltrated. Which of the following is the best immediate response by the nurse?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Stop the infusion, remove and re-site the cannula</li><li>2. Apply a cool compress to the site</li><li>3. Apply Paraffin gauze dressing</li><li>4. Gently massage the IV site</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The nurse should stop the infusion, remove the IV cannula, and restart the infusion at another site. </li><li>A cool compress doesn’t promote fluid absorption. As cannula needs to be removed, this is considered as the initial priority.</li><li>Moist heat shouldn’t be applied until the infusion is stopped, the catheter is removed, and another catheter is inserted at a different site.</li><li>Massaging the site will cause pain at the IV line. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 81</h3>
                <p><b>Which of the following represents the criteria of a good research problem?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Feasible</li><li>2. Significance to nursing profession</li><li>3. Original</li><li>4. All of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Characteristics of a good research problem are:<ul ><li>Significance to nursing profession</li><li>Original</li><li><b>Feasible:</b> Time, administrative support, peer support, availability of subjects, researcher’s competence, ethical considerations</li><li>Solvable </li><li>Current</li><li>Interesting </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 82</h3>
                <p><b>Sources of research problems can include:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Researchers’ own experiences as educators</li><li>2. Practical issues that require solutions</li><li>3. Theory and past research</li><li>4. All of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Identification of a research problem is the first and most important step in research process. A research problem may come from several sources.<p><b>Sources:</b> <ul ><li>Personal experiences</li><li>Practical experiences</li><li>Critical appraisal of literature</li><li>Previous research</li><li>Existing theories</li><li>Social issues</li><li>Brainstorming</li><li>Intuition</li><li>Folklores</li><li>Exposure to field situations</li><li>Consultations with experts </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 83</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is not a type of non-probability sampling?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Quota sampling</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Snowball sampling</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Cluster sampling</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Convenience sampling</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Cluster sampling is not a type of non-probability sampling; in fact, it is a type of probability sampling method. Probability sampling is also known as random sampling method which means that there is an equal chance for each participant to become the part of the research sample. In this, the chances of bias are also minimized, that&rsquo;s why it is preferred over non-random/non-probability sampling.</li>
</ul>
<p><strong>Flowchart:</strong> Types of probability sampling techniques</p>
<p><img title="image019.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/669fbeb1-0eb4-483e-8099-31bdd5e0df95.jpg" alt="" width="409" height="153" /></p>
<ul>
<li>In cluster sampling, the population is made of units or clusters and a sample is taken from them in multiple stages, as shown in the image below.</li>
</ul>
<p><img title="image020.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/1781eac9-ca06-442a-89ec-8b41976fa33c.jpg" alt="" width="315" height="270" /></p>
<p>&nbsp; <strong>Figure</strong>: Image of cluster sampling</p>
<ul>
<li>Options a, b and d are types of non-probability sampling.</li>
</ul>
<p><strong>Flowchart</strong>: Types of non-probability sampling techniques</p>
<p><img title="image023.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/d55bfde0-64f9-475f-a0da-3434022d02c3.png" alt="" width="393" height="130" /></p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 84</h3>
                <p><b>When would you write an abstract?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. After the main body of the report has been drafted</li><li>2. Once the result has disseminated</li><li>3. After the introduction of study</li><li>4. After data collection</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>An abstract should be written once the main body of the research report has been drafted because it summarizes the key points of the study, including the purpose, methods, results, and conclusions. Writing it after the complete report ensures that the abstract accurately reflects the content and findings of the study. It is usually located at the beginning of an article.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 85</h3>
                <p><b>Which one of the following statements is most accurate about hypothesis?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Hypotheses represent the main idea to be studied and are the foundations of research studies.</li><li>2. Hypotheses help frame a test for the validity of a theory.</li><li>3. Hypotheses provide the means to test nursing theory.</li><li>4. Hypothesis can also be called a problem statement.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Although theories cannot be tested directly, hypotheses provide a bridge between theory and the real world. A hypothesis is a predetermined declaration regarding the research question in which an investigator makes a precise, educated guess about a study outcome. </li><li><b>Option A:</b> It is the research question that represents the main idea to be studied. Investigators conducting studies need research questions and hypotheses to guide analyses. </li><li><b>Option C:</b> Theories cannot be tested directly. </li><li><b>Option D:</b> The research question is also called the problem statement. Any research problem or statement is grounded in a better understanding of relationships between two or more variables. Research questions do not directly imply specific guesses or predictions; the researcher must formulate research hypotheses. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 86</h3>
                <p><b>What is the characteristic of a hypotheses?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. It flows from interpretation of the collected data.</li><li>2. It operationally defines the variable to be studied.</li><li>3. It eliminates the need to designate a dependent variable.</li><li>4. It implies a causative or associative relationship.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>A hypothesis implies a causative or associative relationship. Investigators conducting studies need research questions and hypotheses to guide analyses. Starting with broad research questions (RQs), investigators then identify a gap in current clinical practice or research. </li><li><b>Option A:</b> A hypothesis guides the research design and collection of data. </li><li><b>Option B:</b> Operational definitions are not included in the hypothesis. A hypothesis is a predetermined declaration regarding the research question in which an investigator makes a precise, educated guess about a study outcome. </li><li><b>Option C:</b> A hypothesis indicates a dependent variable. It states a presumed relationship between two variables in a way that can be tested with empirical data. It predicts the relationship between independent and dependent variables. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 87</h3>
                <p><b>A null hypotheses is rejected, when:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. There is no association among variables.</li><li>2. There is evidence of significance.</li><li>3. The independent and dependent variables are related.</li><li>4. The research hypothesis is rejected.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Since the null hypothesis states that there is no relationship between the independent and dependent variables, it is rejected if they are related. H0 symbolizes the null hypothesis of no difference. It is presumed to be true until evidence indicates otherwise. </li><li><b>Option A:</b> A null hypothesis is a characteristic arithmetic theory suggesting that no statistical relationship and significance exists in a set of given, single, observed variables between two sets of observed data and measured phenomena. </li><li><b>Option B:</b> An alternative hypothesis (research hypothesis) proposes that there is a difference. A null hypothesis proposes that there is no difference between variables. </li><li><b>Option D:</b> If research hypothesis is rejected, then null hypothesis is accepted and vice versa. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 88</h3>
                <p><b>Which among the following is considered as the importance of acquiring clinical knowledge and expertise according to Benner (1984)?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Authorities</li><li>2. Borrowing from other disciplines</li><li>3. Personal experience</li><li>4. Research</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Option C:</b> Based on her research, Benner proposes that a nurse’s personal experience affects the breadth and depth of that nurse’s knowledge and expertise. </li><li><b>Option A:</b> Benner did not emphasize on acquiring clinical knowledge and expertise through authorities. </li><li><b>Option B:</b> Benner did not emphasize on acquiring clinical knowledge and expertise through borrowing from other disciplines. </li><li><b>Option D:</b> Although research is important, it was not the focus of Benner’s description of knowledge acquisition. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 89</h3>
                <p><b>A variable that changes due to the action of another variable is known as:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Complex variable</li><li>2. Extraneous variable</li><li>3. Dependent variable</li><li>4. Independent variable</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Dependent variable varies because of the changes made to independent variable by a researcher. </li><li>Complex variable is an incorrect word. </li><li>Extraneous variables are those variables that are not a part of a study but they affect the results of the study. A researcher has no control over them. For example:</b> Assessing the effectiveness of communication skills on patient’s level of satisfaction. In this, there can be various other factors that will influence the patient’s level of satisfaction. The researcher has no control on them like other facilities, treatment, infrastructure, etc. </li><li>Independent variable:</b> It refers to the manipulation or any intervention given by a researcher. The effect of an independent variable on a dependent variable is studied. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 90</h3>
                <p><b>The outcome of what is being measured is termed as:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. The independent variable</li><li>2. The dependent variable</li><li>3. The predictor variable</li><li>4. The hypothetical variable</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Dependent variable (DV):</b> The outcome variable that is measured in an experiment.</li><li>Independent variable:</b> Manipulated by the researcher to observe any change in the outcome of dependent variable. </li><li>Other options are distractors. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 91</h3>
                <p><b>The statement of beliefs and ideas considered to be true is known as:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Assumption</li><li>2. Conceptual definition</li><li>3. Hypothesis</li><li>4. Operational definition</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The statement of beliefs and ideas considered to be true is known as assumption. The facts that are taken for granted and considered true without any evidence or statistical test. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 92</h3>
                <p><b>To a nurse seeking evidence on a question, a literature review article in a journal would be considered:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. A secondary source</li><li>2. Bibliographic database</li><li>3. Primary source</li><li>4. Tertiary source</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>A secondary source is a description of previously completed studies. Studies usually completed by different people than the one writing the review. </li><li>A primary source is a document or record which reports a study, experiment, event or other firsthand phenomenon. Primary sources are usually written by the person(s) who did the research, conducted the study, ran the experiment, or witnessed the event. </li><li>Other options are distractors. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 93</h3>
                <p><p><strong>The stages of sampling process comprise of:</strong></p><ol><li>Specifying sampling method</li><li>Defining the target population</li><li>Determining the sample size</li><li>Specifying sampling frame</li><li>Sampling and data collection</li></ol></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 2, 4, 1, 3, 5</li><li>2. 1,2,3,4,5</li><li>3. 4, 1,2, 3, 5</li><li>4. 1, 2, 4, 3, 5</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The stages of sampling process comprise of the following steps:</b></li><ul type ="circle"> <li>Identify and define the target population:</b> The first step of the sampling process is identification and defining the target population. The target population consist of the total group of people or objects that meet the designated set criteria of interest of the researcher. </li><li>Ensuring the sampling frame:</b> After establishing a complete description of the accessible population, researcher must have a sampling frame available to select a sample from accessible population. </li><li>Specifying sampling plan or method:</b> Before the selection of a particular sample, a researcher must have a final sampling plan. </li><li>Determining the sample size:</b> It is very essential to determine the sample size, which help the researcher to implement the sampling process. </li><li>The last step is to collect the data from the selected sample population.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 94</h3>
                <p><b>During experimentation, informed consent should include which of the following:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Details of the purpose of the experiment</li><li>2. A description of the procedures the participant will encounter</li><li>3. The duration of the study</li><li>4. All of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Informed Consent:</b> Detailed information about an experiment given to participants in order to enable them to make an informed decision about participation. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 95</h3>
                <p><b>Which mode of clinical application for qualitative research is considered to be the sharing of qualitative findings with the patient?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Insight or empathy</li><li>2. Anticipatory guidance</li><li>3. Assessment of status or progress</li><li>4. Coaching</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Anticipatory guidance is the sharing of qualitative findings with the patient. Anticipatory guidance, specific to the age of the patient, includes information about the benefits of healthy lifestyles and practices that prevent injury and disease. Common examples of anticipatory guidance include reminding parents to have their children use bicycle helmets and to use sunscreen. </li><li><b>Option A:</b> There is no consensus in the general biomedical/clinical literature about disclosing research results to study participants. </li><li><b>Option C:</b> In contrast, there is a body of opinion that cautions against disclosures as a routine practice, even aggregated results, because of postulated potential harm to research participants. </li><li><b>Option D:</b> Coaching is defined as a collaborative solution-focused result-oriented systematic process used with normal non-clinical populations in which the coach facilitates the self-directed learning, personal growth and goal attainment. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 96</h3>
                <p><b>What is the first step in the qualitative research process?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Data analysis</li><li>2. Sample collection</li><li>3. Review of literature</li><li>4. Study design</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Review of literature is the 1st step in the qualitative research process. </li><li>Data analysis is the sixth step in the qualitative research process. </li><li>Sampling collection is the third step in the qualitative research process. </li><li>The study design is the second step in the qualitative research process.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 97</h3>
                <p><b>Evidence-based practice (EBP) is defined as:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Practice based on patient preference</li><li>2. Practice based on the best available research evidence</li><li>3. Practice based on clinical expertise</li><li>4. A process of clinical decision-making based on the best available literature, clinical expertise and patient preference</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>EBP in nursing is a process of locating, appraising and applying the best evidence from the nursing and medical literature to improve the quality of clinical nursing practices. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 98</h3>
                <p><b>Which action will the researcher take to improve construct validity?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Ensure that operational definitions reflect theoretical constructs</li><li>2. Make sure that the researcher is involved in data collection</li><li>3. Utilize only one measurement method to measure study variables</li><li>4. All of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Construct validity depends on adequate definition and measurement of constructs. The conceptual definition should emerge from the concept analysis and the operational definition should clearly reflect both.</li><li>Allowing data collectors to know which subjects are assigned to which groups and involving the researcher in data collection both increase the risk of bias. </li><li>Using only one measurement tool increases the risk of bias.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 99</h3>
                <p><b>Which of the following is most frequently used measure of dispersion?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Range</li><li>2. Median</li><li>3. Standard deviation</li><li>4. None of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Option C:</b> Standard deviation (SD) is the square root of the variance, i.e. S.D. = √σ. </li><li>It is the most commonly used measure of dispersion. It is a measure of spread of data about the mean. It is based on all values and thus, provides information about the complete series. Because of this reason, a change in even one value affects the value of standard deviation. </li><li><b>Option A:</b> Range:</b> It is simply the difference between the maximum value and the minimum value given in a data set. </li><li><b>Option B:</b> Median is a measure of central tendency. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 100</h3>
                <p><b>Number of medication errors in a ward is which type of variables?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Discrete variable</li><li>2. Demographic variable</li><li>3. Continuous variable</li><li>4. None of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Discrete variable:</b> A discrete variable is a variable whose value is obtained by counting. Examples:</b> Number of medication error, number of nurses, types of bed etc. </li><li>A continuous variable is a variable whose value is obtained by measuring. Example:</b> Height of students in class, weight of the students etc. </li><li>Demographic variables are age, gender, educational status, religion, etc.</li></ul></div></div>
        <div class="credits">
            <p class="rainbow-text">Credit: Code Written by BHASKAR</p>
        </div>
        </body></html>